TSS:Rfhg 17057.1

Basic information about the TSS

---

TSS ID: rfhg_17057.1 Species: human Chr: chr1		Start: 185100555 End: 185100557 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF075026:-164 GeneID: 6045 HGNC/MGI_ID: HGNC:10061 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ring finger protein 2 Gene_symbol: RNF2 Gene_synonyms: BAP-1 BAP1 DING HIPI3 RING1B RING2 Gene_source: HGNC:10061

TATA-Box annotation

---

Distance to TSS:	54998
Nearest PromoterID:	NM_007212
Entrez ID:	6045
Nearest Unigene:	Hs.591490
Nearest Refseq:	NM_007212
Nearest Ensembl:	ENSG00000121481
Gene Name:	ring finger protein 2
Gene Alias:	BAP-1|BAP1|DING|HIPI3|RING1B|RING2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNF2 p2@RNF2 p3@RNF2 p4@RNF2 p5@RNF2 p6@RNF2 p7@RNF2 p8@RNF2 p9@RNF2
Sample		p1@RNF2	p2@RNF2	p3@RNF2	p4@RNF2	p5@RNF2	p6@RNF2	p7@RNF2	p8@RNF2	p9@RNF2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.60	6.23	5.65	2.34	1.56	2.34	2.14	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	20.23	9.10	7.49	2.83	2.02	4.05	1.42	3.03	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	24.11	7.14	8.68	3.28	1.35	2.12	1.16	1.54	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	21.00	8.52	5.82	2.08	1.46	3.33	0.83	1.04	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.32	4.72	7.87	3.60	3.60	4.95	1.35	1.35	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.80	5.23	8.72	2.91	1.94	3.29	0.39	1.74	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.88	8.06	7.63	5.01	3.27	3.05	1.96	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.74	10.66	4.84	1.21	2.66	2.91	0.73	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.95	5.77	6.41	4.49	3.85	3.21	1.50	0.85	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	8.69	5.80	3.48	9.85	0.58	2.90	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	4.45	6.47	1.21	10.11	3.23	1.21	3.64	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.80	3.66	7.72	1.63	9.76	2.03	1.22	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.41	8.87	0.16	1.13	0.81	1.13	0.81	1.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.16	7.37	0.75	1.80	0.90	0.45	1.35	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	7.25	0.88	1.54	0.22	0.44	1.10	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.03	4.78	0.25	2.26	0.75	0.25	0.75	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.17	8.30	0.22	1.31	0.22	1.31	0.22	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	5.06	0.42	1.27	0.00	0.84	1.27	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.33	4.80	0.53	1.07	0.53	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.03	8.42	1.05	1.35	0.15	0.30	0.75	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.15	5.88	1.20	1.34	0.40	0.40	1.20	0.94	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.77	7.08	1.04	1.21	1.04	1.04	1.21	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.24	8.27	0.78	1.03	0.52	0.78	1.03	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.34	6.07	0.24	0.97	0.49	0.49	0.73	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	8.77	0.52	2.32	0.77	0.77	0.26	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.01	6.33	0.63	0.95	0.63	0.63	0.32	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	7.69	1.10	2.20	1.65	1.10	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	7.54	0.47	0.94	0.47	0.94	0.71	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.17	7.43	0.81	2.58	1.29	1.45	0.81	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.06	4.16	1.45	1.09	0.18	0.90	2.35	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.28	5.44	0.42	1.88	0.00	0.84	0.84	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.23	6.45	0.98	0.78	0.39	1.17	1.37	1.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.81	5.28	1.27	1.27	0.42	0.21	0.84	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	7.09	1.65	1.65	0.49	0.99	0.33	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.29	5.05	0.93	0.93	0.37	0.75	1.68	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.39	5.75	1.34	1.92	0.96	1.34	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.18	5.31	0.41	1.02	0.61	0.82	0.82	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.04	3.63	1.61	0.40	0.20	0.60	0.20	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.56	5.40	0.54	0.27	0.27	1.35	0.00	1.89	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.36	3.84	0.48	1.20	0.00	0.96	1.44	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.65	3.29	0.24	0.47	0.94	0.47	1.18	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.37	4.68	1.02	1.46	0.44	0.88	0.88	1.02	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.96	4.85	0.84	0.42	0.63	0.42	1.48	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.12	3.67	1.40	0.87	0.35	1.05	1.57	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.43	4.22	0.00	0.60	0.60	0.80	1.81	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.75	4.42	1.40	2.09	0.23	1.16	0.47	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.92	4.80	0.72	0.96	1.44	0.48	0.24	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.24	6.86	2.09	0.00	1.49	1.19	1.79	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.86	4.79	2.39	0.72	0.48	0.48	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.28	3.84	0.81	0.40	0.81	0.40	0.20	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.99	3.69	1.43	0.61	1.02	0.82	1.02	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.79	6.89	1.56	0.67	1.11	0.22	1.33	1.56	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.45	3.55	1.06	0.35	0.71	0.71	1.42	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	3.65	1.33	1.33	0.33	2.32	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	0.84	1.68	0.00	0.00	3.36	0.00	5.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.70	2.76	0.00	1.38	0.92	0.46	0.00	3.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.37	3.57	1.30	0.65	0.65	2.27	1.62	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.96	2.57	1.28	0.96	0.00	1.28	2.25	2.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.83	5.66	1.57	0.94	0.63	0.63	0.63	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	0.71	0.00	0.00	0.71	0.00	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.09	3.36	1.68	1.12	0.00	0.56	1.12	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	4.78	1.59	1.59	1.59	2.39	0.00	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.17	4.76	1.70	1.36	0.68	1.02	0.34	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.00	2.27	1.30	1.30	0.32	0.65	1.62	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.58	5.32	1.42	0.35	0.00	0.35	1.06	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	7.90	0.00	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	6.34	1.46	0.98	0.49	0.98	0.00	2.44	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.45	6.45	2.48	1.98	0.00	0.50	0.50	2.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	4.69	0.94	1.88	0.94	0.94	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.30	5.30	0.33	2.65	0.00	1.32	0.66	3.64	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2.78	3.71	0.62	0.93	0.62	0.00	0.93	2.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.11	5.20	0.61	0.61	0.61	0.61	0.31	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	4.75	7.13	1.74	0.32	0.32	0.79	0.32	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	5.29	5.61	2.09	1.44	0.16	0.96	0.80	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	6.11	7.12	1.40	0.76	0.51	0.51	0.51	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	0.75	2.99	0.75	0.00	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.68	7.70	1.00	0.00	0.00	0.33	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	4.47	6.38	0.00	0.00	0.64	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	5.50	1.10	1.10	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	2.26	8.13	2.26	2.26	0.45	0.90	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	2.78	3.82	0.52	0.52	0.17	0.52	0.52	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	10.17	4.50	2.15	0.59	0.20	0.78	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	7.72	4.12	3.09	0.26	0.51	0.77	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	10.59	9.20	3.35	1.95	0.56	0.28	1.12	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	4.11	2.35	1.76	0.59	0.59	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.40	8.85	5.87	1.29	0.24	1.05	0.48	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	9.04	4.52	2.90	0.97	0.65	0.32	0.32	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	5.87	8.00	1.07	0.53	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	6.68	2.23	1.11	0.00	0.56	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	7.49	2.08	1.25	0.42	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	7.03	1.76	0.75	0.25	1.26	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	6.87	4.58	2.29	0.33	0.33	0.65	0.98	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	2.74	2.13	0.91	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	3.09	2.65	0.88	1.10	0.22	0.22	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	1.08	0.00	0.00	0.72	0.00	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.86	1.44	0.36	0.36	0.18	0.00	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.49	1.85	0.41	1.03	0.00	0.82	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.93	6.41	1.03	1.95	0.46	0.69	0.23	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	4.65	5.14	0.24	0.98	0.73	0.98	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	4.04	1.35	0.00	0.45	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.42	2.60	1.30	1.30	0.87	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.07	2.69	2.39	0.90	0.90	0.30	0.90	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	3.79	0.00	1.26	0.00	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	1.32	1.32	0.00	0.66	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	2.92	1.95	0.97	0.32	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.22	2.91	1.94	0.49	0.00	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	2.97	1.78	0.00	0.00	0.59	0.59	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	3.39	1.51	1.13	0.38	0.75	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	3.63	0.00	1.45	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	0.00	3.76	0.00	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.21	3.46	1.48	0.66	0.66	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	0.00	0.00	0.00	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.40	3.17	1.21	1.36	0.30	0.45	0.15	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	1.61	0.00	0.00	0.00	0.54	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.64	2.65	0.76	0.19	0.76	0.38	0.38	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.95	2.14	1.87	0.53	0.27	1.07	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	2.93	1.95	0.98	0.98	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.62	2.99	1.00	1.33	0.66	0.33	0.66	0.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	1.20	0.00	0.00	2.40	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.12	2.06	1.54	0.34	0.00	0.86	0.51	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	1.94	1.46	0.00	0.49	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	6.45	0.76	0.00	0.00	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	3.63	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	0.57	1.71	0.00	1.14	0.00	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.19	3.85	1.50	0.43	0.43	0.43	0.21	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	2.06	1.55	0.77	0.00	0.26	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	1.41	0.47	0.94	0.00	1.41	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.00	4.18	0.32	0.32	0.96	0.00	0.64	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	2.14	0.71	0.71	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	5.85	0.00	0.00	0.58	0.58	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	4.22	0.00	0.30	0.00	0.60	0.30	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	3.56	1.19	0.00	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	2.54	0.00	0.51	0.51	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.68	2.55	0.25	0.51	1.02	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	4.45	0.00	0.00	1.27	0.00	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.06	0.86	0.86	0.00	0.00	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.62	4.23	1.06	0.85	0.85	0.42	0.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.86	2.32	0.87	0.87	0.29	0.00	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	4.72	0.94	0.00	0.00	1.89	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.02	2.54	0.51	0.34	0.51	0.00	0.17	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	0.00	0.00	2.32	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	2.11	0.00	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.36	3.65	0.21	0.86	0.43	0.00	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	1.80	1.80	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	2.19	0.00	0.00	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.80	2.53	1.38	0.69	0.46	0.00	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	5.10	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.44	1.78	1.78	0.76	0.51	1.02	0.51	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.40	3.51	0.62	0.21	1.03	0.21	0.21	0.83	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.79	3.37	0.92	0.92	0.61	0.31	0.92	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	1.43	0.00	0.48	0.00	1.43	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.09	2.44	2.22	0.44	0.67	0.22	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	1.53	0.00	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.63	2.77	0.55	0.00	0.00	0.55	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.21	1.85	0.53	0.26	0.53	0.26	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	4.00	1.45	0.73	0.00	0.36	1.09	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	5.28	4.79	0.12	0.86	0.25	0.74	0.74	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	2.57	4.11	0.17	1.03	0.17	1.20	0.51	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	2.31	1.68	0.63	0.21	0.21	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	6.97	2.09	0.70	2.44	0.70	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.41	5.82	0.65	2.59	1.46	0.65	1.13	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	19.99	9.70	2.39	1.79	0.89	1.49	0.45	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.48	10.90	0.92	2.87	0.57	1.38	1.38	0.11	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.67	13.03	1.63	4.26	1.25	2.63	2.38	0.13	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.91	11.38	1.48	1.71	0.91	2.96	2.28	0.00	0.11
Basophils, donor1	12241-129G9	14.38	2.09	2.35	0.00	0.78	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	26.70	5.05	10.46	1.08	0.36	0.36	0.00	0.00	0.36
Basophils, donor3	12243-129H2	19.70	1.47	6.03	0.59	0.44	0.59	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	0.22	2.37	0.65	0.86	0.00	0.22	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.00	1.83	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	8.16	1.88	0.00	1.26	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.91	4.37	0.62	1.04	0.00	0.83	0.62	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	1.61	3.45	0.69	2.30	0.23	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	4.86	5.94	0.36	1.26	0.18	0.54	0.18	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.95	3.92	0.52	0.52	0.31	0.31	0.21	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.43	0.47	0.93	0.00	0.70	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	18.55	7.35	4.16	2.24	0.32	2.24	2.56	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	1.69	2.82	0.56	0.56	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	23.57	2.41	3.53	1.48	0.56	0.37	0.74	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	18.22	2.20	3.95	0.44	0.22	0.00	0.88	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.53	4.25	0.85	1.70	1.98	0.28	0.57	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.99	3.41	3.03	1.14	0.76	0.76	0.76	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	4.27	1.64	0.66	1.64	1.64	1.64	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	40.47	4.91	2.02	0.72	1.45	0.72	0.29	1.45	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	34.10	3.02	2.11	0.91	2.11	1.51	0.00	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	52.35	3.55	3.32	0.71	4.26	0.24	0.71	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.98	2.85	4.18	1.00	2.01	0.33	0.84	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.85	3.31	3.59	2.21	1.10	0.83	0.55	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.96	5.70	6.20	1.98	1.98	0.25	0.50	0.74	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	52.67	6.85	11.75	2.35	8.03	1.17	0.59	1.17	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	46.65	6.77	9.26	1.07	5.52	0.18	0.89	0.89	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	71.82	5.44	13.06	2.18	6.96	0.22	0.44	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	34.18	3.04	4.92	0.00	1.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	34.85	4.22	5.81	1.06	2.64	0.00	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	2.22	4.44	0.00	1.11	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	35.25	3.72	3.72	1.49	2.68	0.15	0.00	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	37.91	5.19	3.19	0.20	4.59	1.00	0.60	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	54.55	3.54	6.87	1.46	2.91	0.62	0.00	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	27.23	2.75	3.20	1.37	2.75	0.23	0.23	1.14	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	38.45	3.39	4.30	0.68	2.04	0.45	0.45	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	34.48	2.62	3.93	0.44	2.18	0.87	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	75.32	9.68	8.88	2.69	5.11	0.81	0.81	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	62.28	7.85	6.80	2.97	5.76	1.22	1.05	1.57	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	73.22	8.00	5.05	2.95	8.42	2.95	1.26	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	31.23	4.96	3.31	1.29	2.57	0.73	0.55	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	47.56	4.58	9.86	2.11	5.64	0.00	1.06	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	56.60	3.07	8.77	2.63	6.14	0.44	0.44	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	34.53	5.06	6.28	3.14	3.84	0.70	0.35	1.22	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	42.74	2.97	6.32	1.49	5.58	1.12	0.74	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	58.20	5.82	9.92	0.65	5.17	0.22	0.43	0.22	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.44	6.96	6.14	1.64	2.87	0.41	0.41	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.19	3.48	8.34	1.16	4.17	0.70	0.70	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	50.11	3.94	9.74	1.39	4.18	0.70	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	33.57	4.36	2.40	0.44	1.31	0.65	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	32.80	3.46	1.39	0.69	0.92	0.69	0.00	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	30.11	3.90	1.73	0.65	1.08	0.43	0.43	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	27.41	3.58	1.87	1.09	1.87	0.31	0.31	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	28.99	4.37	1.05	0.87	1.57	1.57	0.35	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	43.26	2.90	1.78	0.22	1.78	0.89	1.11	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	31.90	2.30	1.28	0.51	0.26	0.00	0.51	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	39.74	2.63	2.63	0.44	0.22	0.44	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	37.69	1.47	1.47	0.42	1.05	0.63	0.21	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.09	7.46	2.71	0.68	0.68	2.03	5.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	4.14	3.11	0.00	1.04	0.00	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.31	3.73	5.33	2.13	1.07	1.60	1.60	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	25.73	4.82	3.75	2.68	1.07	1.07	2.14	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	2.81	2.81	1.40	0.70	0.70	2.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	28.24	8.63	2.35	3.14	0.78	0.00	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	3.95	3.95	1.32	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	27.94	3.29	2.47	0.00	1.64	1.64	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	25.39	3.63	5.08	2.18	0.00	0.00	0.73	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	20.70	4.54	6.06	1.01	0.00	1.51	1.01	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	31.92	48.08	16.57	2.02	2.02	0.00	0.00	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	24.77	36.75	15.98	3.99	5.59	0.80	2.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	6.02	7.03	1.00	0.00	1.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.28	8.43	16.85	1.12	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.30	6.76	3.76	3.76	1.13	3.38	2.25	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	21.42	9.47	2.71	2.93	0.68	2.71	1.35	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	28.92	5.00	9.28	0.71	1.07	0.71	0.36	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	25.11	1.84	11.02	0.00	0.00	0.61	1.84	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	34.77	6.71	6.71	1.52	0.30	0.30	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	32.42	6.89	3.83	0.51	1.28	0.51	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	34.81	11.45	3.14	1.12	1.12	0.67	1.35	0.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.62	8.05	7.19	1.15	1.72	0.00	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.70	8.06	5.22	1.42	0.95	0.95	1.42	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.99	4.92	2.81	0.70	0.00	0.70	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	6.59	13.18	0.00	0.00	3.30	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.08	7.95	2.60	0.87	0.43	0.72	0.14	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	18.81	8.13	1.86	1.02	0.34	0.34	0.17	1.02	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	18.38	7.90	1.93	1.45	0.64	0.16	0.97	1.13	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.31	8.07	3.14	2.69	0.00	0.45	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.12	8.39	5.24	1.75	1.75	1.05	1.40	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	27.72	5.28	3.08	0.88	0.44	0.00	0.88	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	4.22	2.11	0.00	1.69	1.69	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.48	5.61	1.87	0.62	0.00	0.83	0.83	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.05	5.01	1.34	1.34	0.33	0.33	0.33	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.97	5.71	2.18	3.26	0.27	1.09	0.27	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	49.31	4.82	3.75	1.61	0.00	0.00	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	7.17	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	20.95	8.90	2.78	1.11	0.93	0.74	0.37	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.98	7.80	2.60	0.65	0.87	0.43	0.43	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.17	6.30	3.57	0.42	0.63	0.42	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.26	6.57	3.54	1.52	0.51	1.01	1.01	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	21.66	4.77	6.93	2.17	1.30	0.87	1.73	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.74	4.36	5.23	1.74	0.44	0.44	1.31	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	24.74	9.40	4.45	2.97	0.00	0.00	2.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	25.85	4.62	5.54	0.92	0.00	0.00	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	8.37	1.40	1.40	0.00	1.40	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	38.77	10.80	2.77	1.66	0.28	1.94	0.55	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	38.28	9.82	5.64	1.96	0.98	2.70	0.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	3.08	3.08	0.00	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.72	6.09	5.01	1.43	0.72	0.72	1.43	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	9.69	8.31	6.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	25.54	6.22	15.71	2.29	0.33	0.65	0.65	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	25.15	8.63	16.14	1.50	0.00	1.13	1.13	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	34.09	5.05	9.59	1.77	0.50	0.50	0.76	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.11	9.41	3.67	1.15	0.23	2.06	2.29	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.35	9.11	4.31	2.64	0.72	2.16	1.20	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.65	8.21	3.56	1.92	0.55	1.92	1.09	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.40	9.61	3.00	3.30	0.90	2.70	1.80	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	12.24	3.60	3.60	1.20	2.64	1.68	0.96	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.46	9.55	4.55	1.59	0.68	3.18	1.36	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.26	7.39	1.30	2.17	0.87	2.39	1.30	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.26	7.90	2.11	2.11	0.79	2.90	0.79	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.39	9.38	3.99	2.35	1.41	3.05	0.94	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.34	9.36	2.72	2.42	0.60	2.42	0.91	1.21	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.97	10.75	3.78	2.32	0.58	2.03	1.16	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.20	11.19	3.20	1.33	1.60	3.73	1.87	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.76	9.19	2.19	3.50	1.31	0.88	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	6.38	1.82	1.82	0.91	0.91	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.97	4.48	1.49	2.98	2.24	2.24	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	14.41	6.12	3.96	1.08	2.52	2.88	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.16	10.93	5.47	2.88	0.86	3.16	2.01	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.48	10.61	4.71	3.06	0.00	4.01	2.59	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.44	8.87	4.12	3.80	1.27	4.75	1.58	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.31	9.53	3.08	2.15	0.31	3.08	0.62	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.09	9.94	2.24	1.60	0.32	4.49	1.92	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.18	10.33	3.44	2.29	0.38	3.44	1.53	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.12	7.88	3.55	0.79	0.79	1.18	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	7.56	3.03	3.03	1.51	0.76	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	3.21	0.80	1.61	0.80	0.80	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	8.39	3.50	0.00	2.10	0.70	1.40	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	10.02	7.01	0.00	0.00	4.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	1.83	9.14	1.83	0.00	0.00	3.66	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.93	3.46	0.99	1.98	0.99	0.99	1.98	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	9.58	9.47	2.21	1.79	1.05	1.26	1.47	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	7.63	9.36	2.43	1.04	0.00	0.35	0.00	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	4.62	3.20	1.07	0.36	0.00	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	7.05	6.14	1.14	1.37	0.46	0.46	0.23	0.80	0.23
Chondrocyte - re diff, donor2	11339-117F7	20.59	25.07	1.79	0.90	1.79	1.79	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	6.47	7.28	1.21	0.40	0.40	0.40	1.21	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	15.15	14.34	2.07	3.67	1.15	1.03	1.95	0.34	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	9.62	1.92	3.21	0.64	1.71	2.14	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	10.62	8.85	1.50	3.27	0.71	1.59	1.50	0.18	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	14.67	7.15	2.11	2.11	0.92	1.93	1.47	0.09	0.09
Corneal Epithelial Cells, donor1	11526-119I5	2.20	2.63	0.00	1.54	0.22	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	2.28	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.79	3.58	0.00	0.26	0.00	0.26	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.41	5.78	1.49	2.31	0.50	1.32	1.16	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.52	5.99	1.89	1.58	0.63	1.26	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	17.25	0.00	3.45	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.88	5.51	0.65	1.19	0.65	0.97	1.51	0.54	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.74	4.44	5.81	0.68	0.68	0.34	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	7.18	3.92	0.65	0.00	0.65	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.94	2.90	4.36	0.48	0.00	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	5.17	4.34	1.33	1.33	0.17	1.50	0.83	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	3.52	4.11	1.76	0.00	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.37	7.64	1.70	1.13	0.00	0.28	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	5.11	1.57	1.97	0.00	1.57	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	1.45	2.04	0.29	0.58	0.58	0.58	1.16	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.71	7.29	1.18	1.41	0.00	1.41	1.41	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	2.63	5.96	1.23	1.58	0.00	1.58	0.70	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.43	7.54	2.44	1.33	0.89	1.55	1.33	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	7.30	3.65	0.61	0.61	1.22	1.22	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.87	6.77	1.41	2.54	0.56	1.97	2.26	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	2.38	1.78	2.08	0.30	0.30	0.59	0.89	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	3.64	2.08	0.52	0.52	0.52	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.40	2.55	0.28	1.13	0.28	0.99	1.42	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	10.40	5.20	3.20	0.40	0.40	2.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	2.62	2.62	1.05	0.52	0.00	1.05	1.57	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	13.05	6.83	3.60	0.87	1.74	1.74	0.12	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.34	9.34	2.39	1.74	1.09	1.30	1.09	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.26	9.16	3.79	1.95	0.49	1.34	1.71	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	4.55	4.55	4.55	1.14	1.14	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	3.49	5.59	2.79	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.26	5.50	3.14	1.57	0.16	1.41	1.10	0.00	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	37.96	4.95	11.55	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	3.57	14.27	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.49	2.93	0.00	1.22	0.49	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	8.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	7.80	3.69	1.23	1.64	0.00	0.00	0.82	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.05	2.19	0.77	0.11	0.00	0.00	0.22	0.77	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.61	8.13	1.08	1.19	0.76	0.43	0.33	2.17	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	6.55	7.16	1.09	1.70	0.24	0.61	0.85	0.36	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4.64	3.14	1.09	0.27	0.14	0.14	0.14	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7.38	5.59	0.74	1.27	0.42	0.21	0.32	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3.69	4.22	1.05	0.53	0.00	0.00	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	5.98	7.31	2.33	0.66	0.33	0.66	0.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	3.63	4.54	1.81	1.36	0.91	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	3.03	3.79	0.76	0.00	0.00	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.94	2.68	1.26	0.47	0.16	0.16	0.63	0.16	0.47
Fibroblast - Cardiac, donor4	11452-119A3	14.55	8.18	5.15	1.21	0.91	1.21	1.52	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	9.14	6.60	1.78	1.27	0.51	0.51	0.89	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	8.94	7.73	1.67	1.21	0.45	1.67	0.30	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.91	5.36	0.27	0.80	0.40	0.40	0.94	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.22	3.02	1.29	0.00	0.43	0.86	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	2.93	0.00	1.46	0.00	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.00	4.61	0.69	3.46	1.61	1.61	2.54	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	12.72	8.82	1.70	1.53	0.85	0.68	0.85	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	4.70	9.16	1.88	1.88	0.47	0.47	0.94	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	3.30	5.19	0.94	0.47	0.00	0.47	1.89	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.75	7.98	1.57	2.30	0.24	0.85	0.85	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	7.23	13.00	1.92	3.39	1.02	1.13	2.03	0.45	0.23
Fibroblast - Dermal, donor5	11454-119A5	7.85	15.70	2.27	3.31	0.35	1.74	1.74	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	9.10	14.13	2.76	3.57	1.14	1.46	1.62	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	6.25	10.00	1.87	1.67	0.21	1.04	0.62	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.86	8.65	1.83	1.57	0.00	1.31	0.52	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	6.98	10.94	1.19	1.98	0.40	0.26	0.92	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	8.22	10.44	1.16	1.84	0.19	0.77	0.77	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	9.35	1.04	1.04	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.70	4.05	0.88	2.29	0.00	0.53	0.35	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	11.22	7.79	3.27	2.65	0.16	0.94	0.47	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.06	10.55	2.16	1.22	0.54	0.68	0.54	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.23	3.53	1.06	0.71	0.00	1.06	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.21	9.21	2.63	2.05	0.88	0.73	0.88	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.00	6.00	2.45	0.82	0.55	0.55	0.55	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.85	11.19	3.07	1.21	0.55	1.54	0.77	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.11	8.80	3.23	2.35	1.32	0.15	0.15	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	13.43	2.98	0.00	0.00	2.98	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	4.43	8.02	2.32	3.59	0.00	0.21	0.84	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	0.00	4.17	0.83	0.83	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	5.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	1.12	0.00	0.56	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	4.87	7.71	1.22	2.44	0.41	2.44	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	7.18	11.64	1.94	2.33	1.55	1.55	0.97	0.97	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	7.74	17.90	2.43	3.79	0.46	1.06	1.82	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.43	14.99	3.06	1.22	0.00	2.14	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.01	3.82	0.00	1.14	0.00	1.14	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.56	3.51	1.62	0.54	0.00	0.27	1.08	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5.45	4.41	0.70	0.81	0.00	0.35	0.58	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	6.08	6.19	1.22	1.22	0.99	1.11	1.33	0.44	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2.03	6.71	0.81	1.42	0.00	1.22	1.02	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	0.00	1.34	0.67	1.34	0.67	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	8.70	2.37	2.77	0.79	0.40	0.79	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2.98	4.17	1.79	0.60	0.40	0.79	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.95	7.46	0.53	1.24	0.53	1.07	0.71	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.07	8.87	2.37	1.77	0.59	0.79	0.59	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	4.51	5.72	1.50	0.60	0.30	0.90	0.30	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.36	9.93	1.62	0.86	0.43	1.40	0.32	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.30	3.29	0.76	0.25	0.25	0.00	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	6.07	5.41	1.64	0.98	0.16	0.66	0.33	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	4.21	6.22	1.40	0.60	0.20	0.80	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	6.73	7.23	1.71	1.21	0.40	0.70	0.30	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.16	7.25	1.51	0.60	0.91	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.20	8.78	2.73	2.32	0.50	1.24	0.33	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.35	5.98	1.71	1.03	0.85	0.34	0.68	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.28	3.61	1.31	0.99	0.00	0.99	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.24	8.42	2.45	1.28	0.64	0.85	0.64	0.43	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	5.57	7.42	1.69	0.51	0.51	1.01	0.51	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.21	6.27	0.63	1.25	1.10	0.47	0.31	1.25	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	11.33	0.00	0.00	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.75	8.32	3.29	1.04	0.69	0.69	0.87	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.19	7.81	3.90	1.30	1.04	1.56	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.26	6.64	2.30	0.51	0.77	0.51	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	65.84	9.19	3.83	2.30	6.12	2.30	1.53	13.01	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	63.17	8.29	7.66	1.28	7.02	1.28	1.28	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	61.62	8.84	3.99	4.56	5.99	2.28	2.00	4.28	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	67.01	11.86	2.21	3.58	3.58	1.93	2.48	4.69	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	52.74	5.48	1.83	3.65	5.25	0.91	1.60	1.83	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.47	7.53	2.18	4.76	5.75	3.57	3.17	4.95	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	75.07	7.40	1.32	4.23	3.44	0.53	1.85	8.19	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.08	6.20	0.98	1.63	3.59	1.30	2.28	2.61	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	55.28	10.61	1.33	5.75	5.31	2.21	2.21	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.83	5.51	1.27	3.67	5.79	2.40	2.40	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	40.64	9.36	1.72	2.59	3.82	1.72	1.85	0.12	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.31	6.45	1.07	3.49	2.95	1.07	2.15	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.79	10.04	1.98	5.95	3.47	2.60	2.23	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.77	9.97	1.80	5.12	4.29	2.77	2.08	0.55	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.14	9.35	2.24	3.05	3.25	1.42	2.44	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.29	7.99	0.91	2.28	2.51	1.37	0.91	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.63	7.35	1.62	3.86	2.49	1.74	1.37	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	30.82	10.93	1.09	4.81	3.06	1.75	2.62	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.91	7.39	0.00	3.84	1.48	0.59	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.08	7.79	2.23	3.18	3.18	1.91	2.07	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.48	7.15	1.12	3.80	3.57	1.12	1.34	0.45	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.24	7.86	1.81	2.42	3.43	1.01	1.01	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.55	11.54	2.04	4.41	3.90	1.70	1.19	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	31.30	11.44	1.86	5.14	3.19	1.95	1.06	0.18	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.36	11.86	0.94	4.06	2.81	1.35	1.98	0.00	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.96	10.25	1.54	2.05	4.61	1.54	0.68	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.32	10.51	1.11	3.43	2.10	1.55	1.77	0.11	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.29	7.57	2.66	2.83	3.33	1.83	1.75	0.42	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.20	6.53	1.23	1.63	3.68	0.82	0.61	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.82	6.19	0.83	2.89	3.09	0.83	1.44	0.41	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.59	8.53	1.50	2.65	2.65	1.27	1.50	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.01	5.84	1.00	3.17	2.50	1.33	1.17	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.04	7.49	0.66	2.65	2.42	0.88	1.54	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.17	8.36	0.74	1.97	2.09	0.86	1.48	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.88	7.94	1.46	1.78	2.11	1.46	1.13	0.32	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.66	8.34	1.28	1.92	1.60	1.28	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.65	6.82	0.19	2.75	2.37	1.04	1.33	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	16.13	5.54	0.79	1.90	1.42	0.47	1.42	0.47	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.37	8.21	0.91	0.91	1.52	0.61	2.43	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.29	8.15	2.51	3.35	2.30	1.25	1.78	0.63	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.44	6.37	1.54	1.98	1.10	0.88	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.48	4.21	1.40	3.65	2.52	1.12	1.12	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.78	7.59	1.48	1.48	1.94	0.93	1.67	0.28	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.17	5.88	0.53	1.34	1.34	1.60	0.80	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.79	7.04	1.07	1.68	1.22	1.22	1.53	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.99	6.48	1.55	2.20	0.78	1.04	1.30	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.98	5.15	1.08	2.17	2.17	1.36	2.98	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.35	8.30	1.47	2.03	1.66	1.29	1.66	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	15.35	7.24	1.75	1.32	1.54	0.88	1.54	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	16.86	0.00	1.98	2.98	1.98	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.61	9.37	1.32	3.03	0.79	1.06	0.79	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.68	8.47	0.81	4.24	0.61	0.40	1.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.48	13.72	2.29	2.29	2.80	3.05	0.76	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	41.21	5.77	0.60	3.98	8.36	2.59	2.39	0.40	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	33.13	5.55	0.77	3.85	5.24	2.00	2.93	0.46	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.17	6.75	1.43	5.32	5.73	3.48	4.50	0.61	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	45.06	5.32	3.44	2.50	4.07	2.82	0.94	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.10	5.93	3.39	2.26	3.67	0.28	1.41	0.28	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	56.27	7.84	4.61	1.84	3.23	2.31	2.77	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	4.95	2.47	14.85	7.42	2.47	2.47	2.47	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	41.78	6.58	4.25	1.16	4.64	1.16	1.93	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	11.23	3.21	0.00	6.42	1.60	0.00	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	3.48	0.00	0.00	5.22	5.22	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	34.83	7.81	2.93	2.28	4.23	3.58	3.25	2.60	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.41	7.82	4.53	2.06	4.53	2.47	1.24	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	10.00	0.00	13.33	0.00	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	43.63	10.91	2.80	1.96	6.15	1.40	1.12	2.80	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	38.57	9.48	4.90	3.92	4.58	0.98	3.92	1.96	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	8.39	1.68	5.03	3.36	3.36	1.68	6.71	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	40.08	12.72	2.54	4.13	3.82	2.54	0.95	0.95	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	35.66	11.21	3.40	3.40	4.42	1.02	0.68	1.36	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	16.71	2.09	6.26	0.00	0.00	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.95	13.17	3.44	8.02	4.01	1.15	1.15	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.23	9.77	1.48	3.26	2.07	1.18	0.89	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	13.55	6.78	1.69	5.08	0.00	0.00	11.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.63	10.77	4.56	4.56	6.21	1.66	0.41	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	45.11	7.82	4.83	2.99	5.29	0.92	1.61	1.38	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	5.27	5.27	0.00	5.27	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	36.52	8.46	3.08	2.31	6.92	0.77	0.77	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	43.35	10.43	5.22	1.63	4.89	1.30	0.33	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.14	9.36	3.34	6.02	2.01	0.00	0.67	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.84	13.87	1.93	3.08	4.62	1.16	1.16	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.13	6.85	11.30	1.71	12.67	2.40	0.34	1.71	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	7.45	4.97	4.97	4.97	0.00	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	59.45	12.74	1.42	5.19	3.30	1.89	2.36	2.83	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	11.47	0.60	5.43	2.41	1.21	1.21	2.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	46.29	5.60	1.02	2.03	3.56	1.53	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.86	10.77	1.60	3.19	1.99	0.40	1.99	1.60	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	47.86	12.83	0.00	1.97	3.95	1.48	0.49	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	47.22	11.80	2.36	3.54	7.08	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	38.51	8.75	0.00	4.67	6.42	1.17	0.58	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	51.79	7.46	0.44	3.07	2.63	0.88	0.88	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	43.23	10.17	2.54	3.39	4.24	1.70	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	36.41	7.16	0.00	1.19	1.79	0.00	1.19	1.19	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.94	5.34	4.85	1.46	6.79	0.97	0.49	0.97	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	4.57	4.57	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.91	3.33	1.25	0.83	0.00	0.00	1.25	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	9.00	1.12	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1.90	2.85	0.95	0.00	0.95	0.63	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	0.84	0.00	0.00	0.42	0.42	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.33	8.01	1.97	2.67	0.93	1.16	1.16	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.50	9.79	1.01	2.70	1.01	1.35	1.01	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.70	11.15	1.59	1.82	0.23	1.14	0.91	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.44	10.17	1.31	3.17	0.55	0.98	0.55	0.44	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.46	9.24	1.50	1.50	1.07	1.50	0.64	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.98	9.04	2.37	2.58	1.08	1.72	0.65	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.34	7.35	1.87	2.86	0.75	0.87	0.87	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.61	6.18	0.86	1.89	1.03	0.69	0.51	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.65	7.69	1.60	1.60	0.32	1.60	0.96	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	2.80	0.00	1.68	0.00	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	5.19	0.87	1.73	0.43	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	2.64	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.88	4.59	1.76	1.41	0.00	1.06	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	2.18	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.29	5.25	1.40	0.35	0.17	0.17	1.22	0.52	0.17
Hepatocyte, donor1	11523-119I2	7.26	1.21	1.21	0.00	0.00	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	11.85	3.23	1.08	1.08	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	6.75	3.68	0.00	0.61	0.61	0.00	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	17.62	5.22	1.31	1.31	0.65	2.61	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.75	8.39	1.22	2.80	1.05	0.70	0.00	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.51	10.15	3.16	1.51	1.10	0.82	0.96	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	0.00	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	2.77	0.00	2.77	0.00	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	10.01	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	5.13	2.56	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	3.25	1.62	1.62	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	5.00	0.00	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	2.65	2.65	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	4.43	3.33	3.33	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	5.67	3.78	3.78	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	6.19	3.09	1.55	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	4.52	3.23	2.58	0.65	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	4.83	6.44	1.61	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	11.95	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	8.15	0.81	0.81	0.00	0.81	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	4.20	1.68	0.84	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	6.43	1.61	0.00	0.00	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	3.69	0.92	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	6.61	3.78	1.89	0.47	1.89	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	3.63	1.81	1.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	4.30	1.08	0.00	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	3.81	1.27	2.54	2.54	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	7.65	3.83	0.64	0.64	0.64	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	3.65	0.00	0.00	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	3.57	0.71	4.28	0.00	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.25	4.63	0.62	1.23	0.31	0.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	7.02	0.00	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	3.14	0.00	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	9.74	1.39	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	6.64	0.00	0.00	0.00	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	0.87	0.00	1.74	0.87	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	0.00	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	6.40	3.20	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	2.77	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	4.60	0.92	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	5.29	0.00	1.06	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	5.47	5.71	1.06	1.47	0.24	0.98	0.16	0.24	0.08
Keratinocyte - epidermal, donor2	11349-117G8	0.59	3.51	1.76	1.76	0.00	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.87	9.56	1.23	2.08	0.66	1.04	0.95	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	11.35	11.35	0.23	2.16	1.14	0.57	1.36	0.34	0.11
Keratocytes, donor1	11527-119I6	3.09	2.75	0.34	1.38	0.34	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	2.34	2.34	0.00	0.00	0.00	3.52	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	6.13	6.72	0.59	2.96	0.00	0.79	0.99	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	4.40	0.00	0.00	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	11.87	5.39	0.00	2.16	3.24	4.31	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	13.26	11.07	0.69	2.08	1.96	1.27	1.15	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	10.90	7.27	2.42	2.42	1.41	1.31	1.01	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.47	4.51	1.42	0.95	0.12	1.30	1.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.07	3.35	0.28	0.56	0.56	0.28	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.66	4.56	2.20	1.26	0.63	1.10	1.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	4.30	1.08	1.08	1.08	1.08	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.99	3.15	0.00	0.63	0.00	0.00	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.67	1.51	0.43	1.51	0.11	0.75	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	5.34	1.64	0.41	0.41	1.23	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.53	2.28	0.00	0.51	0.00	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.94	2.82	0.70	0.56	0.28	0.14	0.28	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	3.96	0.79	1.98	0.00	1.19	0.79	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.72	3.88	1.74	1.36	0.78	0.39	0.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.67	1.48	0.74	0.37	0.00	0.37	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	4.53	2.44	0.35	0.00	1.05	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.16	3.34	2.15	0.95	0.24	0.95	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.26	2.33	0.69	0.41	0.00	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.78	3.39	0.92	1.54	0.62	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	1.56	0.62	0.62	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.56	1.83	1.10	0.55	0.00	0.55	0.37	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.24	2.63	0.99	0.99	0.00	0.99	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.34	1.76	0.29	0.29	0.00	0.00	0.88	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.49	1.49	0.50	0.50	0.00	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.85	1.94	3.88	0.97	1.45	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.16	1.89	2.15	0.81	0.00	0.81	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.39	2.27	1.51	0.76	0.00	0.91	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	4.67	1.04	0.00	0.00	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.31	2.72	2.93	1.26	0.00	0.84	0.21	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.51	2.56	0.90	1.05	0.15	0.45	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	2.06	2.75	1.38	0.00	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.64	3.76	1.51	0.19	0.19	0.38	0.75	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.97	2.33	0.11	0.32	0.11	0.42	0.42	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.60	2.42	3.39	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.29	1.32	0.99	0.99	0.00	0.33	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.73	1.24	0.50	0.37	0.00	0.37	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.66	4.07	1.85	0.74	0.00	1.11	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.93	5.68	2.47	1.48	0.49	0.49	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.57	1.10	0.27	0.41	0.14	0.27	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.79	5.47	0.96	1.93	0.96	0.96	0.64	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.91	4.26	0.91	0.30	0.30	0.61	0.30	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.40	3.78	1.96	1.12	0.00	0.42	0.84	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.02	4.27	1.78	0.71	0.36	1.07	1.07	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	1.94	1.45	0.48	0.00	0.48	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.56	0.93	0.47	0.62	0.00	0.47	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	2.51	2.15	0.00	0.00	0.36	0.72	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.57	2.94	2.29	0.65	0.00	0.65	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.71	1.41	0.47	0.00	0.00	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.05	4.21	0.99	0.74	0.00	0.25	1.36	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.33	2.31	1.54	0.26	0.26	0.26	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.48	0.90	0.30	0.60	0.00	0.00	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	15.86	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.84	12.27	3.07	0.77	0.00	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	8.91	2.23	1.48	0.74	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	7.62	1.69	1.27	0.42	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	6.33	0.70	0.70	2.11	0.70	0.00	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	3.74	4.67	1.87	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	7.73	0.52	2.58	1.03	1.03	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	9.52	2.38	3.57	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.69	7.92	3.39	1.13	0.23	0.45	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.69	6.98	2.33	0.58	0.58	0.58	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	4.50	2.70	1.35	0.45	2.70	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.16	10.03	3.39	3.25	0.68	1.35	0.68	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	7.19	1.54	1.54	1.03	1.03	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.59	5.29	2.12	1.06	0.35	0.71	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	6.00	1.33	0.00	0.67	1.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	8.66	2.55	0.51	0.51	1.02	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	6.94	5.07	3.20	1.33	0.27	1.60	1.07	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	7.18	7.75	3.97	2.65	0.57	0.76	1.13	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.88	3.68	3.68	2.45	1.23	1.23	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.97	11.42	0.82	2.45	0.00	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.08	6.46	3.33	1.46	0.42	1.25	0.83	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.09	7.29	1.12	1.40	0.56	1.12	0.00	1.12	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	7.21	0.00	1.03	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	8.71	7.55	2.61	3.48	0.58	1.16	1.74	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.57	5.98	3.89	1.49	0.60	2.09	1.79	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	8.85	2.77	2.77	0.55	1.66	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.97	10.60	4.24	3.89	1.06	1.06	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.28	9.22	3.32	0.74	0.74	1.84	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	5.76	2.30	1.15	2.30	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.20	10.36	1.54	1.54	0.77	0.00	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	6.23	5.10	2.26	1.13	1.70	0.57	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	4.92	2.46	1.64	0.00	2.46	2.46	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	10.39	1.36	2.71	0.00	2.71	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	8.62	1.44	1.44	0.00	1.44	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.20	11.95	1.49	0.75	2.99	1.49	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.66	11.15	3.34	2.97	0.00	2.23	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.32	12.06	1.72	1.72	0.43	1.29	1.29	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	7.71	1.71	1.71	1.71	1.71	3.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.66	8.66	2.00	3.33	0.67	0.67	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	11.46	1.21	0.00	0.60	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	11.38	2.13	1.42	0.00	0.71	0.00	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.59	9.62	2.06	1.37	0.34	1.03	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.73	9.66	2.15	2.68	0.00	1.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	7.41	2.69	3.37	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.56	13.33	1.48	1.48	0.74	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	13.96	3.49	0.00	0.00	2.33	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	7.40	1.06	0.00	0.00	0.00	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.80	10.40	3.60	1.60	0.80	0.80	0.80	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	3.63	1.45	2.18	0.73	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	9.96	1.53	1.53	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.84	7.40	2.47	0.99	0.49	0.00	0.99	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	9.41	2.82	0.94	0.94	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.05	9.05	4.02	3.52	0.50	0.50	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	15.77	5.86	3.15	1.80	0.45	0.90	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	5.16	0.00	0.00	3.44	5.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	13.36	3.12	2.23	0.00	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	6.26	2.74	1.96	0.39	0.78	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	12.53	8.58	0.00	1.98	0.00	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	5.71	10.38	3.11	3.11	0.00	1.56	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	8.75	3.50	1.75	0.00	0.44	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	5.59	1.68	2.80	0.00	0.56	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	13.25	3.53	0.44	0.88	1.77	0.44	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.19	7.71	3.86	2.31	0.77	0.39	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.13	9.11	2.53	2.03	0.51	1.52	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.17	9.61	0.96	1.44	1.44	1.44	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.93	9.94	3.18	0.80	1.19	1.19	1.19	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	9.72	5.47	1.82	0.61	2.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	4.84	2.77	0.00	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	11.40	12.92	4.56	2.28	0.76	1.90	0.76	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	9.30	3.10	2.58	2.07	1.03	1.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	10.28	3.02	1.21	1.21	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.63	12.04	2.54	1.27	0.32	1.27	0.32	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.93	12.26	5.33	2.67	1.07	1.07	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	12.07	4.60	2.30	1.72	1.72	0.57	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.00	16.97	3.60	1.54	0.51	1.03	0.51	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	14.15	4.24	2.12	1.41	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.65	13.05	5.11	1.70	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.06	10.40	3.74	1.66	0.42	1.66	1.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	22.71	3.13	3.13	2.35	0.00	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	11.69	3.76	0.84	0.84	2.51	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.47	12.55	2.79	2.79	1.39	0.93	0.46	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	17.40	6.69	1.34	0.67	2.01	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.55	17.11	4.81	2.14	1.07	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.53	22.23	2.83	4.45	0.81	1.62	0.81	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	19.27	0.00	4.59	0.92	6.42	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	12.45	5.33	5.33	1.78	2.67	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	14.25	3.99	5.70	0.57	0.57	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	8.44	4.60	6.14	0.00	1.53	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	15.87	3.28	0.55	1.64	2.74	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	20.05	1.78	4.90	1.78	1.78	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	21.84	3.90	2.60	0.78	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14.59	23.87	6.63	2.65	1.33	4.64	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	22.86	2.08	6.24	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	16.64	2.28	1.37	0.68	0.68	0.91	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.18	4.40	0.73	0.73	0.37	0.92	1.84	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	15.21	3.93	1.18	0.66	0.52	0.66	0.52	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	4.25	1.59	0.00	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.93	5.55	1.27	0.63	0.79	0.32	0.63	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	13.76	5.98	3.61	1.11	1.25	0.97	0.97	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	8.47	13.05	1.79	3.59	0.60	1.00	0.80	0.20	0.10
Mammary Epithelial Cell, donor2	11350-117G9	7.24	10.13	0.58	1.74	0.58	1.16	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.99	7.23	0.50	0.25	0.00	0.50	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	28.47	28.47	10.85	2.03	0.00	2.71	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	27.47	12.54	3.46	1.51	1.51	1.51	1.73	0.11	0.76
Mast cell, donor2	11565-120D8	43.39	5.94	3.27	2.67	2.38	0.30	1.49	0.00	0.30
Mast cell, donor3	11566-120D9	35.34	10.13	3.15	1.80	1.80	1.13	1.13	0.45	0.23
Mast cell, donor4	11567-120E1	32.09	5.32	4.08	1.77	1.06	0.35	0.53	0.89	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	23.29	10.20	2.11	1.33	1.33	0.89	0.89	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	10.51	1.75	0.00	0.58	1.17	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	23.86	8.83	3.21	1.26	0.80	1.26	1.15	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	39.16	11.05	3.68	2.18	2.18	0.33	0.67	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	11.94	6.07	2.39	1.99	0.40	1.19	1.19	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	8.31	6.58	2.77	0.35	0.35	1.04	1.04	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	6.52	9.42	1.96	1.96	0.65	0.58	0.65	0.14	0.29
Melanocyte - light, donor1	11274-116H5	2.35	2.12	1.18	0.24	0.00	0.00	0.71	0.00	0.00
Melanocyte - light, donor2	11351-117H1	1.36	2.73	0.68	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	2.60	0.00	0.00	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.66	7.91	2.50	2.08	0.94	0.73	1.15	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	8.61	1.34	2.15	0.27	0.54	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	13.93	10.98	2.68	0.80	1.07	0.80	1.34	0.00	0.27
Meningeal Cells, donor1	11493-119E8	4.59	7.20	1.24	2.36	0.12	1.36	0.87	0.00	0.00
Meningeal Cells, donor2	11573-120E7	9.68	3.96	0.44	1.76	0.44	0.88	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	11.65	14.10	6.19	2.20	0.65	1.30	0.82	0.24	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.56	11.12	0.86	1.14	0.29	0.57	1.14	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.69	7.65	2.62	1.91	0.70	0.40	0.40	0.50	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	3.92	0.00	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	7.18	2.87	0.00	0.00	1.44	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.14	5.29	1.48	1.27	0.00	1.06	0.42	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.52	6.03	2.51	0.50	0.00	0.50	1.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	1.10	4.61	0.44	1.98	0.44	0.44	0.88	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	4.38	0.00	0.73	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.46	3.07	0.41	1.02	0.20	0.41	0.41	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.37	10.53	0.97	1.25	0.28	0.28	0.42	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.12	2.23	0.00	0.00	0.00	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	7.63	6.45	1.84	1.32	0.13	0.66	0.53	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	2.97	0.30	0.00	0.30	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2.56	4.48	0.00	1.92	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.09	9.22	1.77	2.13	1.06	1.42	1.06	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.94	5.32	0.63	0.31	0.31	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	6.53	2.18	0.00	0.73	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.04	3.71	2.39	2.39	0.27	0.53	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	0.00	4.00	1.50	1.00	0.50	1.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.42	4.55	0.87	1.08	0.43	0.72	1.01	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	0.00	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.50	2.46	1.23	0.49	0.74	0.99	0.99	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	4.42	1.47	0.88	0.29	0.29	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.47	3.72	0.31	1.24	0.31	0.62	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.13	5.19	1.24	0.62	0.21	0.41	1.45	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.26	4.00	0.75	0.25	0.75	0.00	1.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	4.65	1.40	0.47	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.36	3.05	1.63	1.22	0.61	0.20	0.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.13	3.56	0.79	0.40	0.79	0.40	1.98	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	2.65	0.88	0.88	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.94	3.04	0.38	0.00	1.14	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	1.32	0.00	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.46	3.18	2.33	0.21	0.64	0.64	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	2.38	1.79	0.30	0.89	0.60	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	2.26	2.51	0.50	0.50	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.79	4.04	0.48	0.71	0.00	0.24	0.71	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.29	3.68	2.30	0.46	0.46	0.23	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.41	1.68	1.05	0.42	0.63	0.21	0.63	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.97	1.63	3.67	1.02	0.20	0.82	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	3.86	1.93	0.86	0.86	0.21	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.33	1.78	0.67	0.89	0.00	0.22	0.67	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.91	2.85	2.19	1.31	0.88	0.88	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	1.52	1.01	1.01	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	1.66	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	2.17	3.26	0.27	0.82	1.09	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.82	2.06	0.29	0.59	0.29	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	1.09	1.09	0.00	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	5.77	7.69	0.96	1.44	0.96	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	3.20	1.20	0.00	0.80	1.20	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.52	2.50	2.50	0.50	1.00	1.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	5.26	4.38	0.88	0.44	0.88	1.75	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	0.00	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	0.64	1.28	0.00	0.00	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.94	6.94	6.20	1.24	0.99	0.25	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	2.78	0.70	0.00	0.70	0.70	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	4.10	0.68	0.68	0.00	0.68	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.50	1.75	0.88	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	0.71	0.36	0.71	0.36	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.26	2.81	1.68	0.28	0.56	0.00	0.84	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	2.08	0.42	0.83	1.66	0.00	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.17	0.00	0.58	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	6.64	1.21	0.60	1.21	0.30	0.30	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	5.01	1.25	0.42	0.83	0.42	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	3.69	1.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	2.85	0.57	0.57	1.71	2.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.49	1.52	0.55	0.28	0.41	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.41	3.11	1.55	0.26	0.26	0.26	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	1.72	0.86	1.72	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	0.00	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	2.14	1.33	0.53	1.07	1.07	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.97	5.39	1.50	0.90	1.20	0.30	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.07	1.84	0.57	0.28	0.14	0.42	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.24	0.96	2.55	0.32	0.32	0.32	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.08	2.21	1.99	0.66	1.33	0.00	1.55	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.31	0.76	0.76	1.14	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.52	5.11	1.70	0.57	1.14	0.57	0.85	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.85	3.20	2.21	0.98	1.72	0.49	1.47	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	1.96	0.65	0.00	0.65	0.00	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.06	1.47	1.18	0.59	0.00	0.29	0.59	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.24	2.88	3.75	0.29	0.58	0.00	1.15	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.07	4.12	1.65	0.41	1.65	0.41	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.83	2.98	2.08	0.60	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00	0.00	3.77	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	1.78	0.00	0.00	0.00	1.78	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	3.94	0.99	0.00	0.00	1.31	0.66	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	0.00	0.00	1.05	0.00	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.23	4.35	1.19	1.19	0.40	0.40	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	3.73	1.86	1.86	0.93	1.86	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.03	4.51	2.25	1.50	0.75	1.13	1.50	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.32	2.66	0.27	0.53	0.53	0.53	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	13.91	2.15	0.79	0.11	0.79	0.23	0.90	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	1.47	1.47	1.47	0.74	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.56	3.66	2.20	0.37	0.00	0.37	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	0.00	0.00	1.56	0.00	0.00	1.56	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	5.34	0.53	1.60	0.00	0.53	1.60	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	1.01	0.00	0.00	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	14.76	3.37	1.26	0.84	0.00	0.42	0.84	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	1.36	0.00	1.36	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.27	0.64	0.64	0.64	1.91	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.01	0.81	1.62	0.81	0.00	0.00	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	3.02	0.00	0.00	0.00	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	5.71	0.00	0.00	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	9.79	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	4.75	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.11	6.03	1.51	1.51	0.65	0.65	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	5.75	1.05	0.52	0.00	0.00	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	5.34	0.67	2.00	0.00	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	3.76	2.50	0.42	0.00	1.67	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.02	9.89	3.42	1.71	0.00	0.95	0.76	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	3.19	4.79	0.00	0.00	4.79	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	6.80	0.00	1.36	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	7.35	5.51	3.68	0.00	9.19	0.00	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.12	5.02	0.84	0.84	0.42	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.62	4.65	1.86	0.70	0.23	0.70	0.70	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	4.32	1.89	0.54	1.35	1.35	1.62	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.67	5.68	2.52	1.26	0.84	0.63	0.63	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.43	3.97	1.49	0.50	0.99	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.45	4.33	3.25	0.27	0.54	0.54	0.27	1.89	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.07	4.08	0.45	0.91	0.45	0.68	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.47	4.25	1.14	0.82	0.16	1.14	0.49	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.40	4.56	2.73	1.46	0.36	1.09	0.36	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	4.24	1.06	1.06	0.53	1.06	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	3.60	3.00	0.60	0.60	0.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.08	7.22	1.97	0.98	0.98	0.33	1.31	1.64	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.97	3.25	0.98	0.33	0.49	0.16	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.29	4.76	1.59	0.88	0.71	1.06	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.28	1.41	1.41	0.70	0.00	0.70	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	4.60	0.00	0.46	0.46	0.92	1.38	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.21	5.78	1.29	0.64	2.25	0.32	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	22.76	6.90	1.38	1.03	0.69	1.38	0.69	2.76	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	7.59	2.53	0.00	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.58	4.68	1.78	0.67	0.45	0.22	0.67	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	4.23	1.69	0.00	1.27	0.85	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	3.56	1.90	0.24	0.24	0.00	0.47	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	2.58	0.86	0.86	0.86	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.33	3.00	2.67	1.33	0.33	0.00	0.00	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.76	2.71	1.35	0.45	0.45	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.54	5.56	1.19	0.40	0.40	0.79	1.19	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	7.43	1.86	0.00	0.93	0.00	0.00	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.54	7.19	1.51	0.38	0.76	1.14	1.51	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	3.91	0.65	1.30	0.00	1.30	0.00	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	3.92	0.44	0.87	0.00	0.87	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.12	5.88	0.45	0.45	0.90	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	12.35	0.00	2.65	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	2.66	1.33	1.33	1.99	0.00	0.66	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	5.46	1.49	0.00	0.99	0.99	0.50	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	3.45	0.77	0.00	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.89	4.84	1.21	1.21	0.30	0.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.05	4.20	1.55	0.44	0.66	0.66	0.22	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	4.07	0.68	2.03	0.68	0.00	1.36	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	13.41	4.88	1.83	1.22	1.83	1.83	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	1.89	0.94	0.63	0.00	0.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.99	4.84	2.42	0.61	0.00	0.61	2.42	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	7.12	1.58	0.79	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	7.94	1.13	4.53	1.13	3.40	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	0.00	30.35	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.47	6.34	1.49	0.50	0.25	0.62	0.25	0.00	0.00
Myoblast, donor2	11322-117D8	7.86	6.71	1.73	1.34	0.38	0.96	0.96	0.38	0.58
Myoblast, donor3	11398-118D3	6.56	7.06	1.35	1.01	0.50	1.51	0.67	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	10.80	10.36	1.75	2.33	0.00	1.02	0.58	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	17.53	6.77	17.22	0.92	0.92	0.62	0.62	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	23.52	6.94	10.55	1.81	0.30	0.00	0.00	0.60	0.60
Natural Killer Cells, donor3	11387-118C1	23.01	6.81	10.49	1.66	0.55	0.18	0.92	0.74	0.00
Neural stem cells, donor1	11275-116H6	77.67	15.97	4.72	3.27	7.26	1.09	0.73	0.36	2.18
Neural stem cells, donor2	11352-117H2	82.80	9.63	3.85	3.85	13.48	0.00	3.85	0.00	0.00
Neurons, donor1	11494-119E9	77.38	13.65	6.83	1.14	7.97	1.14	2.28	0.00	0.00
Neurons, donor2	11574-120E8	44.91	6.60	1.76	1.32	5.72	0.22	0.88	0.00	0.88
Neurons, donor3	11655-122E8	99.48	10.69	2.47	1.64	13.98	0.82	1.64	0.00	1.64
Neutrophils, donor1	11233-116C9	23.20	3.71	5.57	0.00	2.78	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	23.19	8.70	5.80	0.00	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	35.43	3.67	9.77	0.00	3.67	1.83	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	8.67	8.31	1.66	1.90	0.59	0.59	1.54	0.00	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	7.49	6.19	1.95	1.95	0.33	0.00	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.22	5.82	0.40	1.00	0.80	0.40	1.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.30	4.40	0.96	0.41	0.41	0.41	0.41	0.69	0.00
Olfactory epithelial cells, donor2	11934-125I8	10.13	6.22	1.30	1.30	0.29	0.43	0.29	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	8.63	5.33	1.48	1.02	0.34	0.45	0.11	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	7.89	7.40	0.58	1.36	0.39	0.49	0.97	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	9.63	1.81	4.21	0.00	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.96	5.96	0.64	2.55	0.43	0.64	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	4.97	1.86	0.62	1.86	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	1.37	4.30	0.39	0.98	0.00	0.98	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	9.83	8.43	0.00	0.00	3.51	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	7.82	11.02	1.42	1.78	0.53	0.89	1.07	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.42	6.99	1.85	1.52	0.59	1.10	1.01	0.08	0.08
Pericytes, donor1	11491-119E6	2.00	1.78	0.11	0.78	0.11	0.45	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	1.36	0.68	0.23	0.45	0.45	0.23	0.68	0.00	0.00
Pericytes, donor3	11652-122E5	3.46	3.66	0.61	0.61	0.00	0.41	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	5.99	8.93	1.92	1.70	0.34	1.24	1.13	0.23	0.23
Perineurial Cells, donor2	11579-120F4	9.75	6.62	3.40	2.39	0.64	1.38	1.29	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.01	5.42	4.78	0.32	0.64	0.64	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.83	2.94	4.65	0.73	0.24	1.22	0.24	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.59	5.44	4.14	2.07	0.52	0.65	1.04	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	2.63	0.72	0.72	0.24	0.48	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	2.22	1.11	0.00	2.22	3.33	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.32	2.55	0.00	0.00	0.00	0.20	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.11	4.11	0.32	1.27	0.63	1.58	1.27	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	7.13	6.57	3.19	1.13	0.75	1.69	0.56	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.18	3.00	1.96	0.78	0.00	0.26	0.13	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	6.30	5.40	0.90	1.80	0.45	0.68	0.68	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	8.31	7.35	1.28	1.60	0.64	1.07	0.53	0.21	0.00
Preadipocyte - omental, donor2	11329-117E6	7.42	6.55	1.75	0.87	1.31	0.87	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	8.88	6.30	2.58	2.01	0.43	0.86	0.43	0.57	0.00
Preadipocyte - perirenal, donor1	11469-119C2	2.95	0.00	0.00	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.15	8.60	1.84	0.61	0.31	0.00	0.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	13.81	14.70	4.25	2.30	0.89	0.71	1.42	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.81	10.73	2.72	1.70	0.34	1.53	0.85	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	12.95	17.70	3.91	1.96	0.84	1.96	1.49	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	12.89	8.74	3.68	1.38	0.00	0.46	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	9.51	10.55	2.93	1.04	0.31	1.46	0.42	0.73	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.61	8.90	2.41	2.72	3.47	0.75	1.06	0.30	0.60
Prostate Epithelial Cells, donor2	11331-117E8	7.04	6.77	2.03	0.95	0.54	0.81	0.54	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	4.35	8.21	0.55	1.90	0.18	0.49	0.18	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	6.15	3.64	2.51	0.91	0.23	0.23	0.34	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	7.53	8.61	2.51	0.54	0.18	0.54	0.36	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	7.40	6.15	1.88	0.63	0.42	0.21	0.52	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	1.82	0.00	2.19	0.00	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.98	7.14	1.18	2.01	0.42	0.69	0.90	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	0.51	3.55	0.00	4.06	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	2.13	0.71	2.13	0.00	0.00	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.19	9.63	2.43	2.65	0.74	1.48	1.48	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.68	1.36	0.00	1.36	0.68	1.36	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.64	3.77	1.08	1.08	0.13	0.94	0.27	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.99	9.10	2.44	1.55	0.67	1.33	1.33	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	1.33	0.00	0.67	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	2.86	3.74	0.66	2.42	0.00	0.88	0.88	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.00	0.00	1.88	0.63	1.25	2.51	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.94	1.66	0.00	0.83	0.00	0.28	0.28	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3.49	5.64	0.54	1.61	0.00	0.81	1.61	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	3.80	0.00	0.84	0.00	0.00	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.70	3.86	0.39	1.54	0.00	0.96	1.74	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.59	10.11	1.81	3.63	0.78	0.78	1.30	1.04	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.55	7.67	0.85	2.27	0.85	0.28	1.14	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	7.20	0.00	6.17	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.05	7.03	1.25	3.26	1.00	3.01	1.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	23.25	4.94	1.60	1.34	1.34	0.13	0.53	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	12.51	9.83	1.79	0.89	0.89	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	21.46	9.91	2.20	0.55	2.75	1.10	1.65	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	28.42	6.96	4.06	1.74	3.48	1.16	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.08	8.58	1.17	1.17	1.30	2.21	0.65	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.89	11.72	2.18	3.77	0.50	1.09	0.99	0.50	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.41	13.72	4.24	3.12	1.23	1.45	0.45	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.86	13.64	2.98	2.36	1.24	1.61	1.61	0.50	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.15	13.40	2.80	2.80	0.82	1.52	1.28	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.95	13.41	2.77	3.24	1.85	2.31	0.92	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.65	9.72	2.74	2.05	1.10	0.96	0.68	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.94	10.59	2.87	2.27	0.61	1.97	0.61	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.10	14.16	3.40	3.94	0.54	2.69	1.08	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	13.20	11.76	2.58	1.58	2.01	1.58	0.29	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.45	12.66	2.68	2.58	0.75	1.29	1.07	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.15	15.93	3.76	2.21	0.89	2.21	1.11	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.76	8.03	3.25	1.34	2.10	1.72	0.76	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.97	10.71	2.42	2.79	0.75	1.12	1.30	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.23	19.17	3.95	5.83	2.25	1.50	1.13	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.12	8.76	1.86	1.59	1.33	0.93	1.19	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.52	12.46	2.53	3.02	1.07	1.36	1.36	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.04	13.75	4.58	2.67	1.15	0.95	0.76	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.99	10.79	2.67	2.14	1.60	1.39	0.43	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	10.93	1.96	1.68	0.56	2.24	1.12	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.53	11.45	3.42	2.22	0.68	1.20	0.68	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.95	8.02	2.55	1.46	0.36	1.82	0.73	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.19	10.42	2.08	2.70	1.47	2.45	1.10	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.82	11.28	3.90	3.22	2.15	1.34	0.81	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.40	10.14	3.07	1.18	1.42	0.71	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.65	10.52	2.18	4.76	1.39	0.79	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	21.05	14.73	3.51	3.27	1.40	2.10	2.57	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	19.28	13.48	2.70	1.87	1.66	0.21	0.62	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.67	9.51	4.20	2.88	0.88	2.43	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	12.95	4.60	2.09	0.84	1.67	0.84	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.42	15.21	3.36	1.35	1.21	1.75	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.20	8.86	3.07	2.72	0.85	1.36	1.87	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	19.28	13.11	4.24	1.93	1.35	2.12	2.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.93	10.83	2.24	2.41	1.38	1.55	0.52	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.64	8.92	2.06	3.02	1.51	0.69	1.23	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.88	14.12	3.45	3.28	1.64	0.66	0.99	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.78	11.76	1.36	1.87	1.36	1.36	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.41	11.98	2.07	2.96	0.74	2.07	0.89	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.66	9.06	1.87	2.40	1.33	0.53	0.80	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.32	9.68	0.83	1.80	1.11	0.69	0.69	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.57	11.43	1.67	3.57	0.71	1.67	0.95	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.43	14.31	3.43	3.83	2.42	2.62	1.01	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	14.60	10.08	1.60	2.17	1.41	1.60	0.38	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.01	13.28	2.45	3.14	1.05	1.05	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.95	10.28	3.02	3.02	1.81	1.21	1.21	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.65	10.65	1.59	1.84	0.49	0.98	0.49	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.09	15.43	4.22	2.77	2.91	1.75	1.46	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	12.17	10.95	1.22	2.43	4.26	0.61	2.43	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	14.47	12.66	2.41	1.51	1.51	1.51	1.21	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	14.48	10.63	1.58	2.94	1.13	2.04	0.00	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	19.77	17.07	2.40	3.59	1.20	1.20	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.56	9.09	1.42	1.65	1.42	1.06	0.24	0.59	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	15.15	8.32	1.71	2.13	0.64	1.71	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.03	13.22	1.20	4.21	1.80	1.80	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	1.13	5.27	0.38	1.13	0.00	0.19	0.75	0.00	0.00
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	6.13	6.13	0.88	1.10	0.22	1.10	0.66	0.66	0.22
Sebocyte, donor1	11220-116B5	5.48	6.57	0.55	1.10	0.00	1.10	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	3.68	4.14	1.84	1.84	0.46	0.92	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	2.27	3.30	0.21	1.24	0.00	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	9.94	8.28	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.74	8.18	1.67	2.02	0.26	1.06	1.06	0.26	0.18
Skeletal Muscle Cells, donor2	11358-117H8	2.89	1.45	0.00	0.72	0.00	0.00	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	0.84	6.69	0.00	0.00	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	7.70	9.58	1.89	2.51	0.79	0.79	0.63	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	6.99	11.30	2.53	3.12	1.19	0.89	1.19	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	10.47	11.08	1.08	3.23	1.23	2.77	1.23	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	9.70	13.36	2.27	3.02	0.88	1.39	1.39	0.25	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	8.70	12.98	1.14	2.85	1.00	0.71	1.57	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.20	14.09	3.37	3.37	0.89	2.58	1.88	0.79	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.18	6.99	2.95	1.94	1.10	1.43	0.67	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	2.17	0.00	2.17	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.13	6.19	0.83	1.51	0.14	0.28	0.55	0.41	0.00
Skin - palm, donor1	10286-104F7	24.17	2.69	0.00	0.00	0.00	0.00	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.35	2.74	1.01	1.01	0.58	0.86	0.29	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	4.09	3.27	0.00	0.82	0.82	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.36	5.45	1.43	1.43	0.52	0.13	0.26	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	5.56	6.39	0.97	1.81	0.42	0.83	0.28	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	6.61	6.33	0.84	1.27	0.00	0.70	0.28	0.28	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	7.19	4.65	2.96	1.69	0.63	0.85	0.63	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	6.97	7.05	1.95	1.72	0.37	0.60	0.30	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	12.65	2.16	0.62	0.00	1.23	0.31	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4.00	4.00	1.33	0.67	0.22	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	4.70	10.58	1.76	1.18	0.00	0.00	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	4.42	2.21	1.55	0.00	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	0.79	3.15	0.00	0.00	0.00	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	9.27	3.86	0.77	0.77	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	3.00	1.00	1.00	1.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.19	5.32	0.93	1.20	0.00	0.80	0.67	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.09	6.43	1.99	0.66	1.11	0.44	0.44	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.07	7.94	0.77	1.15	0.51	0.51	0.38	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.47	5.21	1.95	0.33	0.65	0.00	1.30	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5.32	8.27	1.77	1.18	0.89	0.59	2.36	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.13	6.26	2.28	1.00	0.14	0.43	0.28	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.46	2.93	0.49	0.81	0.00	0.33	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.31	5.78	1.22	2.44	0.00	0.61	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3.03	7.32	3.03	1.77	0.25	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	4.29	0.48	1.91	0.48	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	4.57	7.96	1.92	0.88	0.44	0.88	0.29	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4.74	7.32	3.01	0.65	0.22	0.43	0.22	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.24	7.35	1.57	1.57	0.21	0.42	0.84	0.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.47	4.18	0.46	1.08	0.00	0.46	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	4.31	0.00	0.00	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	2.69	0.30	0.90	0.30	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	0.68	3.07	0.34	0.00	0.00	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.05	9.42	1.88	2.20	0.55	0.63	0.94	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.76	8.35	2.11	1.11	0.10	0.30	0.60	0.30	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	6.14	4.78	2.96	0.91	0.46	0.91	0.68	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	1.21	0.00	0.00	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8.74	14.04	2.65	2.12	1.85	2.91	2.12	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6.52	5.86	1.73	1.20	0.27	0.27	0.27	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.51	7.76	1.38	0.50	0.38	0.13	0.88	0.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.54	4.57	0.76	0.00	0.76	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	4.37	8.44	2.86	1.06	0.15	0.45	0.75	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	2.25	6.00	1.50	0.75	0.00	1.50	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	2.58	0.00	2.58	0.00	0.00	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3.26	9.30	3.72	0.93	0.47	0.47	2.33	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.52	6.56	1.01	0.00	0.00	0.00	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.39	5.95	0.94	0.00	0.00	0.94	0.94	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	2.95	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.66	14.41	3.92	4.00	0.33	1.58	2.17	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	7.94	1.87	0.93	0.47	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.03	2.30	1.44	0.86	0.14	0.43	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.63	3.82	0.76	0.76	0.25	0.00	1.27	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.88	3.38	0.75	0.75	0.19	0.56	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.69	10.20	1.40	1.40	0.98	1.40	2.24	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.88	8.13	2.09	1.34	1.01	1.09	1.17	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.00	3.33	0.48	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	3.91	0.73	0.98	0.00	0.24	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	6.85	9.50	2.65	0.66	0.22	1.33	0.22	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.68	6.44	0.29	1.17	0.29	0.29	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.75	5.44	1.75	0.39	0.58	0.78	0.00	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	6.61	2.38	0.26	0.53	0.53	0.53	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.58	6.32	2.23	0.74	0.37	0.37	0.37	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.39	5.39	1.80	0.36	0.72	1.08	0.00	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.97	1.99	0.28	0.28	0.57	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	7.88	2.36	0.39	0.79	2.76	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	7.36	5.33	1.52	0.00	0.76	0.25	0.00	1.27	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	8.39	6.79	1.20	0.00	0.00	0.00	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	4.18	3.34	1.25	0.42	0.42	1.67	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	4.58	4.58	1.83	0.46	0.46	0.92	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	4.71	7.24	1.18	2.36	0.50	0.84	0.17	0.50	0.34
Synoviocyte, donor2	11368-117I9	5.87	5.53	1.01	0.17	0.34	0.34	0.67	0.17	0.00
Synoviocyte, donor3	11440-118H9	5.36	4.92	0.22	1.79	0.22	0.67	0.22	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	1.79	3.93	0.36	1.07	0.00	1.79	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.40	2.55	0.46	1.85	0.69	0.69	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	4.30	6.24	1.58	1.86	0.22	1.08	1.08	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	6.96	0.77	3.09	0.00	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.57	3.44	0.00	1.72	0.00	1.72	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.27	6.89	1.72	1.72	0.86	0.49	0.74	0.25	0.12
Urethra, donor2	10319-105A4	50.36	0.00	1.80	1.80	1.80	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	1.59	3.45	0.27	1.06	0.00	0.80	1.06	0.27	0.00
Urothelial Cells, donor2	11600-120H7	1.20	4.41	0.00	1.20	0.00	0.00	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	2.06	3.21	0.23	2.06	0.00	0.46	0.46	0.23	0.00
Urothelial cells, donor0	11216-116B1	10.92	12.48	2.90	1.78	0.22	0.45	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	7.12	0.89	2.67	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	35.74	1.43	1.43	2.86	2.86	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	27.38	2.05	2.05	4.11	1.37	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	33.06	6.20	3.10	0.69	0.69	0.69	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.31	3.49	2.91	0.58	1.16	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	28.11	7.29	1.04	2.08	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	5.51	2.75	2.75	3.67	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	2.74	0.00	0.91	1.83	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	37.50	10.49	4.07	3.45	2.71	1.85	2.96	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	8.80	3.52	2.64	0.88	0.00	0.88	3.52	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.80	10.06	3.35	2.51	0.84	0.84	1.12	0.28	0.84
achilles tendon, donor2	10292-104G4	59.93	4.13	10.33	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.75	7.90	1.78	3.06	2.29	0.51	0.76	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.43	9.29	2.79	1.39	0.23	0.46	0.23	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.94	11.51	2.73	3.09	1.19	1.66	1.42	0.83	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	21.77	20.14	5.71	5.71	0.27	3.54	3.54	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.19	22.21	13.77	5.34	3.94	2.81	3.94	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.17	8.67	5.71	1.69	3.38	2.33	1.69	0.42	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.89	21.78	5.17	7.62	4.63	3.54	2.72	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.74	8.37	3.08	2.20	1.32	0.88	0.88	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.64	8.17	2.04	4.49	0.82	1.63	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.64	9.32	1.94	1.94	0.39	2.33	2.33	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.19	9.75	2.02	1.66	1.10	1.10	1.84	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	11.70	3.90	0.00	0.00	0.00	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	62.98	19.06	18.59	5.11	9.53	2.79	1.63	0.93	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	20.71	7.51	4.66	3.88	1.04	1.29	0.78	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.37	5.84	1.17	2.34	1.17	1.46	0.58	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.24	4.18	1.39	1.39	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	33.31	12.34	4.11	1.65	2.06	2.06	1.23	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.98	3.68	0.92	1.53	0.31	0.92	0.92	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.09	5.55	1.28	0.43	0.43	0.85	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.92	6.07	1.21	1.21	0.61	0.30	1.52	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	12.28	7.70	1.44	2.17	0.48	1.44	0.48	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.61	8.91	6.90	2.23	2.45	1.34	0.67	0.89	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	14.68	13.68	5.00	2.00	1.00	0.33	2.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	3.72	1.86	1.86	1.86	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	28.25	5.65	6.78	1.51	2.64	1.88	1.88	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.24	14.39	3.49	6.54	2.62	2.18	2.18	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	7.50	3.75	0.00	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.13	8.95	2.59	2.35	0.71	0.47	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	18.15	6.05	2.17	3.57	0.62	1.24	2.17	0.47	0.00
adipose, donor1	10184-103D4	154.23	10.56	1.76	2.35	9.38	1.17	0.59	7.04	2.93
adipose, donor2	10185-103D5	39.34	6.08	0.00	0.81	3.24	0.00	0.41	3.65	0.81
adipose, donor3	10186-103D6	53.37	6.26	2.72	2.45	6.26	0.54	0.27	3.00	1.09
adipose, donor4	10187-103D7	120.48	13.00	12.13	0.00	2.60	0.87	1.73	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	17.04	15.47	1.89	4.73	1.10	5.68	6.79	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.54	6.94	0.67	0.80	0.80	0.40	0.53	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.58	7.86	3.22	1.43	0.36	2.14	1.79	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	9.04	6.03	1.16	1.62	0.93	0.46	0.46	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	12.51	2.37	2.03	0.00	0.68	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	9.72	3.24	0.29	0.00	0.59	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	28.46	1.19	0.00	1.19	1.19	1.19	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	29.81	3.45	1.22	1.01	1.82	0.61	1.22	0.41	0.61
amygdala, newborn, donor10223	10360-105E9	26.47	6.46	3.23	1.29	2.58	1.29	0.97	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	9.04	5.98	1.15	2.04	0.38	0.64	0.64	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	25.81	14.12	9.93	5.07	1.54	1.54	2.43	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	18.71	11.69	1.67	3.67	3.01	1.00	1.00	0.00	0.67
aorta, adult, pool1	10052-101G7	10.59	4.12	1.57	0.39	0.78	0.20	0.59	0.00	0.00
appendix, adult	10189-103D9	27.56	5.05	1.94	1.55	0.00	0.39	1.55	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.16	15.48	10.66	4.13	10.32	0.69	1.03	1.03	0.69
artery, adult	10190-103E1	12.23	0.00	1.36	0.00	4.08	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	23.18	3.62	0.87	1.74	2.03	2.46	1.45	0.00	0.58
b cell line:RPMI1788	10427-106D4	17.25	6.69	0.30	2.38	0.74	0.89	0.74	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.94	8.32	1.11	1.11	0.55	0.28	0.55	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.50	7.24	1.39	4.07	0.50	1.49	1.98	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	3.68	3.01	0.33	0.67	0.33	0.50	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	3.91	1.12	1.68	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	15.75	7.28	0.87	2.61	0.87	0.22	0.76	0.22	0.00
blood, adult, pool1	10053-101G8	19.93	2.21	2.21	2.21	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4.28	7.71	2.57	1.71	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	15.52	7.42	0.00	2.02	0.00	0.67	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	21.53	5.13	1.03	1.03	2.05	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	18.26	5.01	1.22	0.78	2.12	0.33	0.45	0.22	0.33
brain, fetal, pool1	10085-102B4	42.74	26.71	2.67	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	19.82	3.63	1.65	1.32	0.66	0.66	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	3.99	3.00	1.50	0.25	0.12	0.12	0.12	0.00	0.00
breast, adult, donor1	10080-102A8	28.41	7.58	3.16	3.16	0.00	1.26	2.53	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.53	9.65	0.51	3.05	0.51	1.40	2.41	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	8.04	1.55	2.78	0.31	0.00	0.00	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.20	23.71	1.15	5.30	1.15	2.99	2.30	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.06	3.39	0.73	1.21	0.73	0.48	0.24	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	17.40	5.17	0.94	0.47	0.47	0.47	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	15.75	7.55	1.09	2.95	1.20	0.66	0.77	0.11	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	24.08	12.04	1.27	2.85	2.54	0.95	0.63	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.88	15.17	6.39	2.93	1.33	1.60	3.19	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	20.72	5.76	1.15	0.00	2.30	0.00	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.74	4.18	0.33	2.18	0.67	0.50	0.84	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	16.81	6.11	0.76	0.76	0.76	0.00	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	24.54	7.32	2.93	1.10	2.93	1.46	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	52.44	8.74	5.83	2.91	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	36.94	8.75	2.78	3.42	1.28	0.85	0.43	0.00	0.64
cerebellum, adult, pool1	10083-102B2	17.25	5.52	0.69	1.03	0.69	0.34	1.03	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	54.80	8.30	2.49	0.83	6.64	0.00	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	20.68	4.29	1.01	0.76	2.02	0.25	0.25	0.25	1.51
cerebrospinal fluid, donor2	10294-104G6	19.00	1.46	5.85	0.73	2.19	0.00	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	22.57	6.33	2.59	1.87	1.44	0.14	0.14	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	10.27	8.45	2.15	1.82	1.49	0.66	0.50	0.33	0.17
cervix, adult, pool1	10013-101C4	26.04	8.71	2.41	2.73	0.52	0.52	1.47	0.42	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.50	3.76	0.84	0.98	0.42	0.56	1.25	0.56	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	2.61	0.00	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	39.27	19.88	1.49	6.34	2.73	1.62	2.61	0.62	0.75
choriocarcinoma cell line:SCH	10785-110H2	27.97	11.21	0.99	4.81	1.72	1.11	2.59	0.37	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	30.60	9.96	0.95	5.22	1.66	5.22	4.98	0.24	0.71
chorionic membrane cells, donor1	12238-129G6	9.40	4.56	1.14	1.42	0.57	0.57	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	11.93	7.76	1.19	2.09	0.80	1.19	0.50	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	16.48	7.69	1.10	2.75	0.00	0.00	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	18.18	11.11	1.01	2.02	2.02	0.00	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.75	8.45	5.38	1.92	1.73	1.92	0.58	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	43.50	12.46	7.39	1.27	3.38	1.06	1.06	0.42	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.14	18.23	4.11	2.82	0.51	2.57	1.03	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.03	20.56	5.08	4.35	2.90	1.21	1.21	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.23	18.53	4.28	4.28	1.83	2.85	1.63	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	27.38	19.43	4.71	4.12	1.47	2.65	0.88	1.18	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	28.93	20.59	11.73	5.47	1.56	4.43	3.39	0.26	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.29	13.26	1.37	4.11	2.06	1.83	1.60	1.60	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.39	7.98	2.08	1.91	0.52	0.87	0.87	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	15.74	8.97	1.65	3.11	2.01	1.28	1.28	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	10.64	8.36	1.52	1.14	0.38	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	11.90	3.57	0.00	2.38	0.00	1.19	1.19	0.00	1.19
colon, adult, pool1	10014-101C5	14.57	5.76	1.76	1.53	0.47	0.94	0.47	0.47	0.12
colon, fetal, donor1	10070-101I7	31.52	11.74	1.85	3.71	1.85	2.47	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	9.17	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.12	10.20	7.22	5.52	2.55	5.95	3.40	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	11.17	15.09	4.68	4.98	1.21	2.41	2.26	0.00	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	8.74	19.88	6.49	3.95	0.85	2.68	3.10	0.00	0.56
corpus callosum, adult, pool1	10042-101F6	16.92	4.31	0.66	0.55	0.11	0.77	0.44	0.11	0.11
cruciate ligament, donor2	10295-104G7	32.42	4.05	1.62	2.43	1.62	0.00	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	6.42	1.61	4.01	2.41	0.80	1.61	1.61	0.80
diencephalon, adult	10193-103E4	13.68	1.68	0.24	0.24	1.20	0.00	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.06	5.74	2.30	3.21	1.84	1.38	2.30	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	28.98	8.46	2.56	2.82	1.80	2.05	0.00	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	8.91	8.18	4.33	2.89	0.96	2.89	0.96	0.96	0.24
ductus deferens, adult	10196-103E7	36.38	1.99	1.00	0.50	3.99	0.50	0.50	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	4.32	1.44	0.00	0.00	0.00	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	8.83	0.00	1.47	1.47	0.00	2.94	0.74	0.74
dura mater, adult, donor1	10041-101F5	14.95	6.85	1.98	1.16	0.58	0.66	0.91	0.00	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	32.64	7.99	7.55	3.55	9.10	1.11	0.67	0.67	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.66	9.17	7.74	2.72	4.16	1.15	1.15	0.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	13.57	2.47	1.85	1.85	0.62	1.85	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	8.17	4.84	1.21	3.63	0.00	3.94	2.72	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.82	7.41	1.54	1.54	0.62	1.54	2.78	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	5.25	1.31	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	39.89	8.72	1.68	2.68	4.36	3.02	1.68	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.61	12.87	2.54	5.26	0.72	3.44	3.44	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.69	4.50	1.61	0.64	1.45	0.96	1.61	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	11.67	10.56	1.67	3.67	0.78	0.67	0.44	0.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.47	12.65	2.75	5.83	0.99	2.31	1.65	0.22	0.11
epididymis, adult	10197-103E8	16.95	5.86	1.47	2.09	0.42	0.84	0.42	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	5.14	5.68	0.71	2.13	0.18	0.89	1.60	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.37	7.47	3.54	1.57	0.39	1.18	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	7.73	5.37	0.39	3.93	0.39	2.10	1.97	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.81	6.50	0.49	4.23	0.69	1.97	2.66	0.10	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	8.51	6.05	1.01	2.80	0.45	1.79	1.79	0.45	0.00
esophagus, adult, pool1	10015-101C6	11.36	5.63	1.17	1.17	0.53	0.85	0.42	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.13	9.52	1.13	3.88	0.38	3.63	4.38	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	16.90	7.24	0.00	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	2.10	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	0.00	0.00	0.00	1.49	1.49	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	24.08	4.59	3.44	3.44	1.15	1.15	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	1.46	7.29	0.00	1.46	0.00	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	48.81	9.15	1.53	2.29	3.31	1.02	0.76	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	8.59	5.13	1.15	2.56	0.00	2.18	1.67	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.52	8.31	2.61	2.37	0.71	0.24	1.42	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	21.02	9.66	1.69	1.03	3.00	0.38	1.31	0.09	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	10.81	11.11	1.80	3.00	0.90	1.80	0.60	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	21.94	14.54	2.56	3.66	0.18	2.19	2.19	0.18	0.09
gall bladder, adult	10198-103E9	9.66	5.79	0.72	0.97	0.24	0.24	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	26.84	9.13	4.29	3.22	0.54	1.61	1.07	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	21.66	8.22	4.48	1.12	0.37	1.12	0.75	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	6.34	3.38	1.90	1.90	0.63	0.63	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.61	6.96	0.39	3.87	0.19	2.13	1.16	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	30.00	13.61	7.38	5.08	2.79	4.26	5.08	0.49	0.82
gastric cancer cell line:GSS	10560-108A2	13.73	23.80	1.83	9.15	0.92	6.41	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	33.35	5.48	1.83	2.06	1.60	0.46	0.69	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	2.75	2.29	0.46	1.72	0.11	0.34	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	15.40	10.92	1.26	5.60	0.84	0.84	2.10	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	6.73	5.74	0.75	3.49	0.25	0.50	0.50	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.67	6.65	2.43	1.48	0.53	1.06	0.21	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.34	7.16	2.39	1.26	0.70	0.28	0.56	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	6.95	8.83	2.76	1.32	0.33	0.77	0.66	0.11	0.00
glioma cell line:GI-1	10413-106B8	24.60	24.02	5.86	3.22	2.05	1.76	1.76	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	24.78	6.56	0.73	0.00	1.46	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	17.82	1.71	0.73	0.98	0.98	0.24	0.98	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	38.34	4.11	0.00	1.37	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.99	4.80	0.53	1.60	2.66	0.53	0.00	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	4.89	7.34	4.89	0.00	4.89	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.96	5.12	0.32	0.64	0.32	0.64	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	54.63	4.59	1.38	3.67	6.89	2.75	1.38	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	48.47	4.12	4.57	0.91	5.94	2.29	0.46	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	60.54	3.22	4.51	0.64	7.09	1.29	0.00	1.29	1.29
hIPS, biol_rep1	14380-156B6	50.31	2.87	7.19	0.00	11.50	1.44	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	43.21	4.12	2.74	0.69	4.80	2.06	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	28.69	2.21	1.10	0.00	1.10	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	4.31	7.18	0.86	2.59	0.00	2.01	2.59	0.00	0.00
heart - mitral valve, adult	10205-103F7	17.34	4.48	1.20	1.20	1.20	0.90	0.30	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	19.61	4.45	0.26	1.31	1.05	0.52	0.78	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	5.83	5.83	0.83	0.83	0.83	0.00	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.61	4.29	1.22	1.63	0.61	0.41	2.04	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	5.54	2.13	0.00	2.55	0.00	0.00	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	15.18	4.60	0.46	1.61	0.46	0.46	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	23.72	8.52	2.05	3.29	2.88	1.33	2.46	0.10	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	5.86	5.86	0.93	0.93	0.00	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	3.57	0.00	1.19	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.24	6.96	2.76	2.76	1.77	1.66	2.98	0.00	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	17.36	6.55	0.85	2.31	1.09	1.58	2.67	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	19.00	8.89	2.32	2.83	1.82	1.01	1.41	0.10	0.30
hepatoma cell line:Li-7	10484-107A7	12.46	4.23	2.11	2.22	0.44	0.78	0.44	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.40	0.10	0.00	0.00	0.20	0.00	0.00	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	35.01	2.84	4.73	1.89	3.79	0.00	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	26.33	5.51	2.04	0.82	2.86	1.02	1.43	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	25.40	4.48	2.49	0.00	3.98	0.50	0.50	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	29.96	2.82	2.11	2.47	2.82	0.35	0.35	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	65.31	6.71	3.05	5.49	4.88	3.66	1.83	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	41.63	5.69	2.36	3.53	3.14	2.16	2.16	1.57	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.62	8.63	1.78	3.30	3.81	1.27	2.29	2.54	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	67.10	11.84	0.56	4.51	5.64	1.69	0.56	3.95	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	72.82	6.71	0.77	4.91	3.10	1.03	2.07	7.49	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	66.81	11.77	0.76	6.07	6.83	0.76	0.76	3.42	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	57.81	5.55	0.88	2.92	7.01	0.58	0.58	3.21	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.47	8.40	0.65	2.80	3.45	0.86	1.29	1.72	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	43.79	7.09	1.25	2.92	5.42	1.25	0.83	2.92	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	41.44	7.58	2.60	1.89	6.16	1.42	0.95	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	43.39	7.55	1.93	3.21	4.18	1.13	0.80	1.77	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	42.42	9.43	4.04	4.04	4.04	2.02	0.67	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.27	5.79	2.03	3.60	4.54	1.56	1.72	0.63	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.83	6.39	1.47	2.46	2.46	0.49	0.00	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	59.35	7.85	4.36	2.62	12.22	2.62	1.75	4.36	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	88.20	7.45	1.15	3.05	5.15	2.10	2.10	3.05	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	89.83	7.41	2.18	1.31	2.62	0.87	0.44	1.74	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	92.96	6.00	3.00	3.50	5.50	1.00	0.50	9.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	49.74	7.35	1.32	0.75	3.96	0.57	0.38	1.13	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	59.57	7.28	1.36	1.36	5.00	0.91	0.45	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	60.77	8.77	0.00	1.57	4.70	0.31	0.31	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	51.44	6.21	1.96	0.65	4.90	0.49	0.82	1.31	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.42	4.94	0.87	1.74	4.94	0.58	0.58	1.16	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	48.43	7.47	2.69	0.90	6.58	0.30	0.90	1.20	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.87	8.68	2.03	4.62	4.43	3.33	3.88	2.40	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	44.50	5.71	2.57	3.42	5.71	2.00	3.99	2.28	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.90	8.98	2.86	2.45	8.17	2.04	0.82	4.08	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	65.49	5.63	2.82	3.52	3.17	1.06	0.35	3.17	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	49.41	8.24	1.58	3.17	5.70	0.95	1.58	2.53	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	67.48	9.38	2.42	2.72	6.36	1.21	1.21	3.33	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.64	5.17	1.55	1.03	6.21	1.03	1.03	3.10	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	57.12	2.66	0.66	0.66	4.65	0.00	0.66	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	45.92	3.59	1.54	0.77	4.62	0.00	0.26	1.28	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.27	4.86	1.79	1.02	5.37	1.79	0.77	1.28	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.82	3.03	2.27	3.03	7.57	0.76	1.51	6.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.45	7.06	2.35	1.01	6.72	0.00	0.00	3.70	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.75	5.07	1.45	2.66	3.62	3.38	3.38	2.17	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.91	12.03	2.67	2.23	4.46	1.34	0.89	6.68	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	51.71	4.88	1.95	2.93	5.85	1.46	2.44	5.37	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	73.35	7.03	1.53	2.44	5.81	1.53	0.61	3.97	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	279.78	16.27	0.00	13.01	26.03	0.00	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	90.35	9.60	1.65	3.97	7.61	1.32	0.66	4.63	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.64	4.93	1.64	0.55	4.38	1.09	1.09	2.19	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.98	6.88	1.09	1.45	2.90	0.72	0.72	2.90	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	46.26	6.76	1.07	0.36	4.27	0.36	0.36	3.56	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	8.35	1.19	0.00	4.77	1.19	3.58	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.71	10.83	3.11	2.71	7.04	1.90	0.95	1.08	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	42.03	7.00	1.62	1.62	4.04	0.00	0.27	2.69	0.00
immature langerhans cells, donor1	11904-125F5	25.67	4.84	6.54	0.97	3.39	0.00	0.24	0.00	1.21
immature langerhans cells, donor2	11905-125F6	15.84	4.75	1.58	0.79	0.79	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	22.81	9.08	2.27	1.04	2.27	1.42	1.32	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	12.03	4.23	1.63	0.98	0.33	0.33	1.30	0.00	0.00
kidney, adult, pool1	10017-101C8	18.72	5.11	2.10	1.30	1.00	0.30	0.60	0.00	0.30
kidney, fetal, pool1	10045-101F9	15.28	7.00	1.41	2.48	0.85	1.49	1.27	0.00	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.49	9.80	1.85	5.11	0.99	2.41	2.98	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.77	4.84	0.55	2.76	0.28	0.55	0.41	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.50	6.06	0.92	2.02	0.00	0.37	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	12.53	1.63	1.09	1.63	0.54	0.54	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	14.66	1.52	0.00	0.00	1.01	0.00	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	4.38	9.30	1.37	2.74	0.27	1.92	0.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	2.16	5.03	0.72	0.36	0.00	0.36	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	2.72	2.72	1.09	0.54	0.54	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	5.83	5.83	0.97	0.00	0.49	0.24	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	6.27	4.18	0.00	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.17	8.85	1.77	3.31	1.30	1.53	1.89	0.12	0.24
liposarcoma cell line:KMLS-1	10782-110G8	9.69	6.25	3.44	0.47	0.78	0.62	1.41	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	10.36	6.94	1.22	1.95	0.12	1.71	2.19	0.00	0.24
liver, adult, pool1	10018-101C9	11.34	1.94	0.97	0.65	0.65	0.81	0.32	0.16	0.00
liver, fetal, pool1	10086-102B5	12.23	1.88	0.94	2.82	0.00	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	19.10	2.04	0.15	1.60	2.62	0.15	0.29	0.29	0.58
locus coeruleus, adult, donor10252	10165-103B3	14.95	3.51	0.74	2.21	1.48	0.37	0.74	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	18.62	3.39	0.56	0.85	1.97	0.85	0.28	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	32.39	2.94	2.52	0.84	2.94	1.26	0.84	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	4.43	4.43	1.52	1.11	0.28	1.25	0.83	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	7.58	2.76	2.07	2.07	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.31	5.80	1.19	2.64	0.92	1.45	0.79	0.13	0.13
lung, adult, pool1	10019-101D1	11.81	6.14	1.54	2.13	0.83	0.24	1.06	0.00	0.00
lung, fetal, donor1	10068-101I5	58.51	11.99	2.00	3.42	4.57	0.86	0.57	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	28.87	5.50	1.83	2.29	0.92	1.37	1.37	0.46	0.00
lymph node, adult, donor1	10077-102A5	21.30	3.31	2.37	5.21	0.47	0.00	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	35.51	9.64	2.63	3.29	2.19	2.41	2.63	0.44	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.86	5.89	2.41	1.81	1.51	1.81	1.81	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	12.74	8.49	4.25	1.70	0.00	0.85	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	5.77	2.66	1.33	0.89	0.00	0.00	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	8.72	2.70	1.25	0.83	0.21	0.21	0.83	0.00	0.00
mature adipocyte, donor3	12233-129G1	7.82	2.84	0.71	0.24	0.47	0.00	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	10.27	3.95	0.79	1.58	0.53	0.00	0.26	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.07	6.43	1.19	1.91	0.95	1.19	2.62	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	6.77	0.00	0.00	5.64	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	22.62	4.78	1.10	1.47	2.57	0.74	0.37	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	26.69	4.13	0.64	0.64	2.22	0.32	0.64	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	69.09	9.81	6.40	1.28	4.26	1.71	0.00	0.00	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	32.40	8.27	0.84	1.01	3.71	1.35	0.51	0.00	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	27.38	4.67	2.55	1.49	2.33	0.21	0.85	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	1.93	1.93	0.00	3.85	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	14.35	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	42.00	8.61	5.38	2.15	4.31	1.44	0.36	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	17.52	4.54	0.65	0.65	1.30	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	16.25	4.18	1.24	2.79	1.70	0.46	0.46	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	11.51	3.84	1.31	1.14	0.90	0.98	0.49	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	17.36	3.82	2.08	1.74	2.08	0.35	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	97.64	22.58	12.18	9.08	11.07	3.76	3.76	0.44	1.11
medulloblastoma cell line:ONS-76	10759-110E3	9.54	7.70	1.47	1.71	0.73	0.73	0.61	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	15.09	8.77	2.73	2.16	0.86	1.44	0.72	0.43	0.57
melanoma cell line:G-361	10465-106H6	14.39	6.79	1.09	1.63	0.27	1.63	0.81	1.09	0.27
meningioma cell line:HKBMM	10691-109F7	3.80	2.71	0.36	3.26	0.00	1.09	0.36	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.89	3.52	1.76	2.64	4.41	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	37.07	8.04	0.52	1.30	2.85	2.33	1.04	1.56	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	10.28	10.43	3.84	1.69	0.92	0.61	0.31	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.18	5.82	4.36	1.82	0.36	1.45	0.73	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.87	4.14	5.80	0.83	0.83	1.24	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.04	6.88	1.55	0.42	0.70	0.00	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.74	6.16	2.12	0.96	0.39	0.58	0.19	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	7.63	7.63	2.78	2.08	1.39	0.00	0.69	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.04	5.32	2.06	1.20	0.17	0.34	0.34	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.52	7.82	2.07	0.69	0.23	0.69	0.58	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	7.69	6.10	1.99	0.93	0.53	0.53	1.06	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.64	6.21	2.16	0.14	0.81	0.95	1.22	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.39	7.54	3.13	1.28	1.00	0.57	0.71	0.57	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	2.63	0.99	0.33	1.32	0.66	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	14.11	8.30	3.18	1.80	0.97	1.11	0.97	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	4.89	9.77	3.49	2.44	1.75	1.05	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.55	5.92	0.61	1.63	0.20	0.61	0.20	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	6.11	0.00	1.08	0.36	0.36	1.80	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.90	6.93	1.86	0.72	0.31	0.83	0.31	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.56	3.65	2.96	0.23	0.23	1.14	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	8.81	8.39	5.45	1.26	0.00	0.00	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.56	6.28	2.24	0.90	0.75	0.60	0.15	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.64	8.93	3.50	1.05	0.70	0.88	0.44	0.26	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	10.31	7.73	1.84	3.31	0.74	1.10	0.00	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.58	4.29	2.58	0.86	1.14	0.00	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	7.58	8.00	1.68	0.42	0.00	0.42	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.39	4.57	2.28	1.83	1.37	0.91	0.46	1.37	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.44	6.39	2.81	1.02	0.51	0.26	0.51	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.76	8.90	1.57	2.36	0.00	1.31	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.47	7.70	0.62	0.62	0.00	0.31	1.54	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.65	8.71	2.82	1.18	0.47	0.47	0.47	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	8.80	2.71	1.02	0.00	1.02	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.68	5.50	2.36	1.57	0.39	0.39	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	7.41	3.24	1.39	0.00	0.46	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.61	6.35	4.90	0.58	0.29	0.87	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.48	7.81	0.89	1.12	0.89	1.34	1.34	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.49	7.21	1.20	0.72	0.72	0.72	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	6.60	6.60	2.20	0.00	1.47	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.73	4.03	0.00	0.67	0.67	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.91	5.32	2.05	0.41	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	4.73	5.58	1.29	0.86	0.43	1.29	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	2.73	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.09	4.22	1.30	2.60	0.00	0.32	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	2.91	1.45	2.91	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.26	12.26	1.07	0.53	0.00	0.53	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	3.27	5.72	2.45	0.00	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.77	4.66	3.11	0.78	0.39	0.39	0.00	1.17	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	0.00	10.49	2.10	0.00	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	8.94	2.98	0.00	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00	0.00	0.00	4.77	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.15	4.15	2.37	1.19	0.00	0.59	0.59	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	4.87	4.87	1.22	0.00	0.00	0.00	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	7.60	1.27	1.27	0.63	1.27	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.97	8.62	3.79	0.69	0.69	0.34	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	2.15	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	13.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	3.26	2.04	0.81	0.00	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	6.36	3.18	0.00	1.59	0.00	0.00	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.13	2.95	1.77	1.18	0.00	0.59	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.23	3.12	1.56	0.31	0.94	0.62	0.62	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	6.68	1.34	1.34	1.34	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	3.55	4.73	1.18	1.18	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	5.14	0.00	0.00	2.57	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	9.64	2.07	0.00	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	9.40	1.98	0.00	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	5.61	3.36	0.00	1.12	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	12.09	5.09	1.27	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	5.64	4.03	0.00	0.40	0.40	0.81	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	4.36	6.54	0.00	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	5.07	5.07	0.00	0.00	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	5.46	3.64	1.21	0.00	0.00	0.00	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	4.52	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	7.41	4.94	0.00	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.73	5.95	2.38	0.79	0.20	0.20	0.20	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.41	4.54	1.95	1.30	0.00	0.65	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	8.15	0.00	2.04	3.06	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	5.42	0.00	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	6.85	13.70	1.89	5.91	0.00	2.60	4.25	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	4.87	3.48	0.93	0.70	0.70	0.23	0.00	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.75	5.34	1.54	0.51	0.41	0.62	0.10	0.21	0.31
mesothelioma cell line:Mero-25	10850-111F4	4.31	4.09	1.36	0.91	0.23	0.23	0.91	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	15.40	9.78	4.40	1.96	0.24	1.22	0.73	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	13.06	5.76	1.77	0.00	0.00	0.22	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	8.94	4.20	1.84	3.15	1.05	1.84	0.79	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	6.13	5.96	1.19	1.53	0.51	0.34	0.51	0.68	0.00
mesothelioma cell line:Mero-84	10855-111F9	2.27	2.78	0.51	0.51	0.00	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	9.52	3.11	1.45	0.83	0.41	0.00	0.62	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	2.15	1.82	1.16	0.33	0.33	0.33	0.50	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	7.60	5.43	1.45	0.72	0.18	0.36	0.18	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	4.44	4.95	0.68	1.20	0.00	0.68	0.17	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	5.85	10.43	1.53	1.78	0.76	2.29	0.51	0.25	0.25
mesothelioma cell line:No36	10857-111G2	12.72	6.85	3.91	0.65	0.33	0.65	0.65	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	11.65	7.04	4.34	1.35	1.90	1.08	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	32.82	9.02	5.57	1.15	2.49	0.58	0.77	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	27.48	9.77	2.69	2.44	1.71	0.49	0.12	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	30.15	8.44	3.95	1.79	2.69	1.26	0.36	0.18	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	11.43	10.45	1.31	2.61	0.33	1.31	2.29	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.21	7.84	2.97	1.91	0.64	0.64	2.76	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.83	2.76	0.46	0.46	0.69	0.23	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.70	10.09	2.28	1.71	0.76	1.14	1.52	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	61.54	21.07	7.39	4.62	2.59	1.85	2.03	0.37	0.74
myeloma cell line:PCM6	10474-106I6	18.58	2.77	0.79	0.99	0.59	0.40	0.00	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.70	2.54	0.00	0.51	0.00	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.26	9.61	3.14	1.18	0.78	0.98	0.20	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.35	6.35	1.11	1.23	0.33	0.22	0.33	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.71	5.96	1.18	1.62	0.22	0.51	0.29	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	17.11	4.97	2.76	0.55	0.55	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	34.05	11.50	2.76	3.91	2.76	1.15	1.15	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	30.87	18.33	4.49	4.68	1.87	2.99	2.62	0.19	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	47.87	8.44	2.32	3.59	4.85	1.69	1.48	0.63	0.63
neuroblastoma cell line:NH-12	10555-107I6	27.21	11.74	0.56	5.22	2.24	1.30	1.68	0.37	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	79.71	21.59	9.73	4.51	4.27	1.19	2.37	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.25	5.23	4.43	2.06	0.95	1.11	1.27	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	14.69	16.10	3.62	6.64	1.61	3.02	2.82	1.61	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	6.36	5.72	0.00	0.64	1.91	1.27	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	11.18	4.26	1.60	1.86	0.27	0.80	0.80	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	37.21	10.15	2.71	3.72	0.68	1.35	0.68	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	38.42	14.41	2.40	5.60	2.40	0.00	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.22	7.05	1.28	1.28	0.32	0.00	0.96	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	5.52	4.47	1.84	0.79	0.26	1.05	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	18.75	7.03	1.12	1.59	2.25	0.66	0.56	0.00	0.94
occipital cortex - adult, donor10196	10172-103C1	51.51	2.06	0.00	2.06	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.84	5.10	0.27	0.81	0.81	0.27	0.54	0.00	1.34
occipital cortex, newborn, donor10223	10355-105E4	43.31	5.82	2.91	0.73	2.55	1.46	0.00	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	38.31	6.04	1.05	0.26	5.51	0.26	0.26	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	205.11	34.76	6.01	9.01	15.88	2.15	3.00	1.29	2.15
occipital pole, adult, pool1	10036-101E9	8.67	4.02	0.55	1.18	0.87	0.32	0.24	0.08	0.08
olfactory region, adult	10195-103E6	16.81	2.29	0.76	0.76	1.15	0.38	0.76	0.38	0.00
optic nerve, donor1	10277-104E7	30.02	0.00	2.00	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.92	8.32	2.51	3.76	0.57	1.82	0.57	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.50	7.14	0.69	2.34	0.82	0.82	0.82	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.19	7.11	1.52	3.39	0.68	1.35	0.68	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.40	6.01	0.92	2.54	1.27	0.58	0.58	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	6.17	5.00	2.06	1.47	0.59	2.06	1.76	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	15.88	5.61	1.87	3.74	0.00	3.74	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	24.81	16.12	9.75	4.03	1.06	3.61	1.48	0.64	0.21
ovary, adult, pool1	10020-101D2	18.96	9.08	3.84	3.58	1.48	1.14	1.75	0.26	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	10.63	1.83	1.65	0.92	1.10	1.65	0.18	0.37
pancreas, adult, donor1	10049-101G4	13.17	1.88	0.00	0.94	0.00	0.00	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.14	8.11	0.84	2.80	0.84	3.91	6.15	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	10.73	5.96	3.24	2.38	0.34	0.85	0.17	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	21.19	9.60	3.81	3.31	0.99	1.32	1.16	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	18.76	6.41	1.28	1.01	1.92	0.55	0.92	0.18	0.73
parietal cortex, adult, donor10258	10373-105G4	38.90	2.94	2.20	0.73	2.20	0.00	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	18.81	5.64	0.94	0.00	3.76	0.00	0.94	0.94	2.82
parietal lobe, adult, donor10252	10157-103A4	22.52	3.99	1.14	0.57	3.14	0.00	0.29	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	16.30	6.70	1.15	1.15	1.76	0.53	0.44	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	165.84	33.94	1.94	8.73	19.40	2.91	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	51.97	8.22	3.74	1.12	4.11	0.75	1.12	1.50	1.87
parotid gland, adult	10199-103F1	25.90	3.70	0.62	2.47	0.62	0.00	1.23	0.00	0.00
penis, adult	10200-103F2	17.19	6.45	0.54	1.61	1.61	0.00	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.18	26.59	2.79	6.51	0.93	0.37	0.74	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.59	6.41	1.75	2.77	0.87	1.46	1.02	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	26.45	1.29	1.94	0.00	0.65	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	60.41	10.66	1.18	3.55	4.15	0.00	1.18	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	35.74	6.90	1.25	1.25	1.88	0.63	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	82.97	2.02	2.02	1.01	3.04	1.01	2.02	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	93.81	6.78	0.00	2.61	4.69	0.52	1.04	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	44.26	0.85	0.85	2.55	1.70	0.85	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	30.53	8.39	2.26	1.40	1.51	1.08	1.83	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	14.17	8.87	2.52	2.52	0.79	0.93	0.66	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.89	10.27	1.71	1.56	0.31	0.62	0.78	0.16	0.00
pons, adult, pool1	10033-101E6	14.20	6.37	0.95	1.46	2.15	0.52	0.17	0.09	0.69
postcentral gyrus, adult, pool1	10032-101E5	11.77	5.67	0.52	0.96	0.78	0.26	0.78	0.09	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	2.09	6.27	0.00	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	11.94	9.32	0.87	3.50	0.44	2.04	2.18	0.44	0.00
prostate cancer cell line:PC-3	10439-106E7	8.89	7.26	1.63	2.36	0.36	2.36	1.82	0.00	0.00
prostate, adult, pool1	10022-101D4	16.78	5.99	1.00	2.00	0.82	1.36	0.63	0.09	0.09
putamen, adult, donor10196	10176-103C5	21.72	3.54	0.71	0.71	1.42	0.00	0.71	0.47	0.47
putamen, adult, donor10252	10152-102I8	13.73	0.00	0.00	0.00	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	2.19	1.09	1.09	3.28	1.09	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	15.70	3.87	0.97	0.48	2.90	0.48	0.00	0.00	0.48
putamen, newborn, donor10223	10365-105F5	26.24	4.50	3.00	1.50	4.50	0.75	1.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	14.26	9.31	1.45	1.16	1.16	1.75	0.58	0.29	0.29
rectum, fetal, donor1	10067-101I4	55.64	9.74	4.17	2.78	5.56	2.78	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.54	9.33	1.27	0.85	0.21	1.70	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.21	14.50	0.83	5.38	0.41	0.00	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	17.10	5.07	1.49	0.80	0.50	0.99	1.39	0.10	0.30
retinoblastoma cell line:Y79	10475-106I7	34.03	12.47	1.56	4.16	2.08	2.34	1.56	0.26	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.07	8.36	1.84	1.35	0.49	2.09	2.46	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	52.58	28.68	13.22	8.15	5.91	5.91	3.66	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	6.06	0.76	0.76	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	6.31	5.83	0.32	0.65	0.16	0.81	0.65	0.32	0.16
salivary acinar cells, donor2	11772-123I8	4.41	4.54	0.41	1.10	0.55	0.55	0.28	0.14	0.00
salivary acinar cells, donor3	11773-123I9	7.94	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	13.73	4.58	0.57	2.29	0.57	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.19	11.89	3.12	2.70	0.51	2.70	1.94	0.51	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.52	13.05	2.12	3.64	0.35	3.53	1.29	0.71	0.00
seminal vesicle, adult	10201-103F3	35.45	3.70	2.12	0.00	3.70	0.00	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	24.29	8.50	3.64	1.46	2.43	0.24	0.24	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	13.84	4.53	2.77	1.76	0.00	1.51	0.75	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	12.04	6.02	4.01	4.01	1.00	3.01	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.52	7.12	2.96	3.22	1.34	1.34	0.54	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	3.09	2.10	0.77	0.66	0.00	0.33	0.00	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.55	5.55	0.90	1.42	0.13	1.29	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	1.42	0.71	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	12.23	4.80	0.72	2.28	2.04	0.24	0.96	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	35.18	12.06	3.02	7.04	2.01	1.01	3.02	1.01	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	6.79	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	62.49	14.52	3.79	3.16	1.26	1.26	0.63	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.68	4.34	2.33	2.33	1.00	1.33	1.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	21.75	6.62	2.21	0.63	2.21	0.63	1.58	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	28.53	21.78	4.05	5.01	0.96	6.17	5.20	2.12	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	33.79	4.29	1.32	1.32	1.65	0.33	0.82	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	54.53	19.46	1.77	10.46	1.93	1.29	1.13	0.16	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.66	4.79	2.18	1.31	0.65	1.09	1.31	0.65	0.44
small intestine, adult, pool1	10024-101D6	9.67	6.81	1.55	0.72	0.60	0.72	0.84	0.12	0.00
small intestine, fetal, donor1	10064-101I1	25.06	9.58	0.74	2.95	1.72	0.74	1.23	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.03	5.64	0.00	0.00	2.56	0.51	1.03	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	13.96	5.17	1.03	2.07	1.55	1.29	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	15.01	3.22	0.80	1.07	0.54	0.54	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	20.19	2.98	0.69	1.38	1.38	0.23	0.23	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	20.50	1.97	1.18	0.79	1.18	1.18	0.79	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	22.83	1.38	0.69	0.00	1.38	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	41.47	13.42	4.27	2.44	3.66	1.83	2.44	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	29.39	4.59	0.92	0.92	1.84	0.00	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.45	5.68	2.39	1.49	0.30	1.49	1.49	0.15	0.00
spleen, adult, pool1	10025-101D7	20.04	4.63	2.86	1.54	0.88	0.99	1.43	0.22	0.11
spleen, fetal, pool1	10044-101F8	11.92	6.75	2.54	2.22	0.40	1.91	1.19	0.16	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.11	6.42	1.04	1.45	1.55	0.83	0.62	0.52	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.39	10.06	1.52	3.80	0.38	0.38	0.57	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.31	7.34	2.10	1.05	1.05	0.70	3.49	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	7.43	2.35	0.78	2.35	1.17	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.08	1.58	1.24	0.45	0.23	0.23	0.00	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	11.01	3.81	4.24	1.27	0.42	1.27	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.19	19.46	5.50	7.19	1.27	5.08	3.81	0.00	0.42
stomach, fetal, donor1	10062-101H8	29.90	7.48	1.07	3.20	1.07	4.27	3.20	1.07	0.00
submaxillary gland, adult	10202-103F4	33.61	5.70	2.85	1.14	0.57	0.00	0.57	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	15.58	3.12	1.87	0.83	0.83	0.21	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	22.24	2.07	1.03	0.00	1.03	2.07	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	25.44	4.95	1.41	0.00	2.12	0.00	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	33.24	17.88	6.42	4.36	3.44	2.29	2.98	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	9.16	5.59	0.59	1.27	0.59	0.34	0.68	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	148.15	24.22	7.83	4.27	6.41	2.85	3.56	0.71	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	74.72	17.14	5.27	4.40	2.64	1.76	3.08	0.44	0.88
tenocyte, donor1	11763-123H8	10.47	8.73	1.05	0.70	0.00	0.70	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	8.77	3.82	0.38	1.91	0.38	0.38	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	5.93	7.78	1.48	0.37	0.37	0.00	0.74	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	66.28	10.88	3.06	4.59	4.42	3.57	2.55	0.51	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	49.48	17.26	4.93	6.47	4.62	3.85	5.55	0.31	1.23
teratocarcinoma cell line:PA-1	10807-111A6	67.73	15.34	1.86	5.42	5.58	2.94	6.35	1.24	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	91.53	17.26	12.06	5.97	9.14	5.20	7.36	3.17	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	62.40	9.45	5.29	6.43	3.40	6.43	6.05	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	100.99	22.90	6.11	11.34	8.40	3.82	2.94	1.09	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	106.83	13.03	6.84	6.51	5.54	1.63	5.54	1.30	0.33
testis, adult, pool1	10026-101D8	26.09	13.96	3.54	4.72	2.25	1.61	2.58	0.32	0.75
testis, adult, pool2	10096-102C6	29.77	18.49	5.41	7.22	3.61	6.32	6.77	0.00	0.45
thalamus - adult, donor10196	10168-103B6	34.22	2.21	0.00	0.00	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	17.97	2.81	1.72	1.09	1.25	0.31	1.25	0.00	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	0.00	0.00	0.00	10.78	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.35	2.96	0.49	0.49	0.49	0.33	0.00	0.99	0.49
thalamus, newborn, donor10223	10366-105F6	35.67	1.73	2.88	0.00	2.88	0.00	1.15	1.15	0.00
throat, adult	10209-103G2	20.72	4.49	2.00	2.25	0.50	0.25	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	37.78	7.01	3.35	1.22	3.05	0.91	1.22	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	16.89	17.49	2.98	1.39	1.39	1.19	0.99	0.40	0.20
thymus, adult, pool1	10027-101D9	20.28	11.13	1.89	1.99	0.89	1.19	1.19	0.10	0.00
thymus, fetal, pool1	10043-101F7	22.55	9.97	2.39	3.12	1.45	1.35	0.94	0.10	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.96	12.23	3.32	2.93	0.66	0.53	1.06	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	14.39	13.13	1.96	4.19	1.40	1.82	2.51	0.42	0.00
thyroid, adult, pool1	10028-101E1	16.42	6.44	1.03	2.71	0.56	1.31	1.21	0.28	0.19
thyroid, fetal, donor1	10060-101H6	31.11	5.80	2.11	1.05	2.90	0.53	2.64	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	0.00	0.00	0.00	0.00	0.00	6.16	0.00
tongue, adult	10203-103F5	10.70	4.19	1.40	1.63	2.09	0.23	0.93	0.23	0.23
tongue, fetal, donor1	10059-101H5	34.68	8.28	1.97	2.36	3.94	0.79	1.18	0.79	0.39
tonsil, adult, pool1	10047-101G2	13.82	5.31	1.90	1.70	0.20	0.60	1.20	0.00	0.20
trachea, adult, pool1	10029-101E2	13.25	8.51	2.04	1.88	0.82	0.65	0.65	0.08	0.08
trachea, fetal, donor1	10058-101H4	26.16	6.92	2.31	3.85	1.92	0.38	1.15	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.09	9.21	3.54	2.13	1.77	0.71	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	21.38	14.39	3.14	1.93	1.52	1.72	1.93	0.10	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	10.97	15.04	1.88	3.76	0.63	2.04	2.04	0.78	0.16
tridermal teratoma cell line:HGRT	10694-109G1	7.61	3.81	1.90	1.90	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.24	6.09	2.54	2.54	0.76	2.12	1.69	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	0.00	0.00	2.09	2.09	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	18.60	6.31	1.19	1.54	1.02	0.68	0.68	0.00	0.34
uterus, fetal, donor1	10055-101H1	43.00	15.87	5.12	3.07	1.02	0.51	1.02	0.51	0.00
vagina, adult	10204-103F6	13.57	2.58	1.29	1.94	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	15.34	4.82	1.97	2.41	0.66	0.66	1.32	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.55	2.14	0.53	0.27	0.27	0.27	0.00	0.00	0.27